DEF 14A 1 ny20031467x2_def14a.htm DEF 14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒	Definitive Proxy Statement

☐	Definitive Additional Materials

☐	Soliciting Material under §240.14a-12

GETAROUND, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒	No fee required.

☐	Fee paid previously with preliminary materials.

☐	Fee computed on table required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

TABLE OF CONTENTS

July 3, 2024

To Our Stockholders:

You are cordially invited to attend the 2024 Annual Meeting of Stockholders, or the Annual Meeting, of Getaround, Inc., which will be held virtually on Wednesday, July 31, 2024, at 10:00 a.m., Pacific Time. The Annual Meeting will be a completely virtual meeting, conducted only via live webcast on the internet at www.virtualshareholdermeeting.com/GETR2024. There will be no physical location for the Annual Meeting. You will be able to attend and participate in the Annual Meeting online, submit questions during the meeting and vote your shares electronically. In addition, although the live webcast is available only to stockholders at the time of the meeting, following completion of the Annual Meeting, a webcast replay will be posted to the Investor Relations section of our website at getaround.com.

The matters expected to be acted upon at the Annual Meeting are described in the accompanying Notice of Annual Meeting of Stockholders and proxy statement. The Annual Meeting materials include the notice, the proxy statement, our annual report and the proxy card, each of which is enclosed.

Please use this opportunity to take part in our affairs by voting on the business to come before the Annual Meeting. The proxy materials, including the accompanying notice, proxy statement and form of proxy are first being distributed and made available to the Company’s stockholders on or around July 5, 2024. Only stockholders of record at the close of business on June 27, 2024, may vote at the Annual Meeting and any postponements or adjournments of the meeting. All stockholders are cordially invited to participate in the Annual Meeting and any postponements or adjournments of the meeting. However, to ensure your representation at the Annual Meeting, please vote as soon as possible by using the internet or telephone, or by mailing the proxy card in the postage-paid envelope provided, as instructed in the proxy card. Returning the paper proxy card or voting electronically does NOT deprive you of your right to participate in the virtual meeting and to vote your shares for the matters acted upon at the meeting.

Your vote is important. Whether or not you expect to attend and participate in the Annual Meeting, we encourage you to vote in advance of the Annual Meeting by submitting your proxy electronically via the internet or by telephone or by completing, signing and dating the proxy card and returning it in the postage-paid envelope provided.

Sincerely,

Eduardo Iniguez

Chief Executive Officer

TABLE OF CONTENTS

GETAROUND, INC.

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

July 3, 2024

Date and Time:	Wednesday, July 31, 2024, at 10:00 a.m., Pacific Time

Place:	Via live webcast on the internet at www.virtualshareholdermeeting.com/GETR2024.

Items of Business:	1.	Elect (i) the two Class I directors named as nominees in the Proxy Statement, each to serve until the annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2025, and (ii) the two Class II directors named as nominees in the Proxy Statement, each to serve until the annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2026, and, as to each, until their respective successors are elected and qualified, or their earlier death, resignation, disqualification or removal.

	2.	Ratify the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2024.

	3.	Approve an amendment to our certificate of incorporation to effect a reverse stock split of our issued and outstanding common stock at a ratio of not less than 1-for-10 and not greater than 1-for-50, with the exact ratio and effective time of the reverse stock split, if any, to be determined in the sole discretion of the Board of Directors.

	4.	Approve, for purposes of the rules of the New York Stock Exchange, the potential issuance of more than 19.99% of our outstanding common stock upon the conversion of our outstanding convertible notes following an adjustment to the conversion rate of the convertible notes.

	5.	Approve, for purposes of the rules of the New York Stock Exchange, the potential issuance of more than 19.99% of our outstanding common stock upon the exercise of certain outstanding inducement grants.

	6.	Approve the amendment and restatement of the Getaround, Inc. 2022 Equity Incentive Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 4,000,000 shares and increase the annual evergreen percentage increase to the number of shares of common stock reserved for issuance thereunder.

	7.	Authorize and approve a repricing of certain stock options issued under the Getaround, Inc. Amended and Restated 2010 Stock Plan and 2022 Equity Incentive Plan that are held by eligible service providers.

	8.	Transact any other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.

	These items of business are more fully described in the Proxy Statement accompanying this Notice.

TABLE OF CONTENTS

			By Order of the Board of Directors,

			Spencer Jackson General Counsel and Secretary

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING TO BE HELD ON JULY 31, 2024: THIS NOTICE, THE PROXY STATEMENT, FORM OF PROXY AND ANNUAL REPORT ARE AVAILABLE FREE OF CHARGE AT WWW.PROXYVOTE.COM.

TABLE OF CONTENTS

GETAROUND, INC.

P.O. Box 24173

Oakland, California 94623

PROXY STATEMENT

FOR ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON JULY 31, 2024

This proxy statement (this “Proxy Statement”) and related proxy materials are being furnished in connection with the solicitation of proxies by or on behalf of the Board of Directors (the “Board”) of Getaround, Inc. (“Getaround” or the “Company”) for use at our Annual Meeting of Stockholders, to be held via live webcast on the internet at www.virtualshareholdermeeting.com/GETR2024 on Wednesday, July 31, 2024, at 10:00 a.m., Pacific Time, or at such other time and place to which the meeting may be adjourned or postponed. Stockholders of record as of June 27, 2024 (the “Record Date”), are invited to attend the Annual Meeting and are entitled to vote on the proposals described in this Proxy Statement. References in this Proxy Statement to the “Annual Meeting” also refer to any adjournments, postponements, or changes in location of the Annual Meeting, to the extent applicable.

The proxy materials, including this Proxy Statement and our annual report on Form 10-K for the fiscal year ended December 31, 2023 (the “Annual Report”), are first being distributed and made available on or about July 5, 2024, to all stockholders entitled to vote at the Annual Meeting.

As used in this Proxy Statement, references to “we,” “us,” “our,” “Getaround” and the “Company” refer to Getaround, Inc. and our consolidated subsidiaries. Information contained on, or that can be accessed through, our website, including the investor relations section of our website at investor.getaround.com and our blog at blog.getaround.com, is not intended to be incorporated by reference into this Proxy Statement and references to our website address in this Proxy Statement are inactive textual references only.

PROXY SUMMARY

This summary highlights information that is described in more detail elsewhere in this Proxy Statement. This summary does not contain all the information you should consider before you vote, and you should read the entire Proxy Statement carefully before voting.

General Information

Annual Meeting of Stockholders
Date and Time:			Wednesday, July 31, 2024, at 10:00 a.m., Pacific Time.

Place:			Via live webcast on the internet at www.virtualshareholdermeeting.com/GETR2024. To participate in the Annual Meeting, you will need the 16-digit control number included on your proxy card or on any additional voting instructions that accompanied your proxy materials.

Record Date:			You are entitled to notice of, and to vote at, the Annual Meeting only if you were a Getaround stockholder as of the close of business on June 27, 2024 (the “Record Date”).

Voting:			Each share of common stock that you own represents one vote. You may vote via the internet, by telephone or by mail. For specific instructions on how to vote your shares, refer to the section entitled “General Information about the Annual Meeting” of this Proxy Statement, your proxy card or on any additional voting instructions that accompanied your proxy materials.

TABLE OF CONTENTS

Voting Matters and Board Recommendations

Proposal	Description	Board Vote Recommendation	Page Reference (For More Information)
1	Elect (i) the two Class I directors named as nominees in this Proxy Statement, each to serve until the annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2025, and (ii) the two Class II directors named as nominees in this Proxy Statement, each to serve until the annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2026, and, as to each, until their respective successors are elected and qualified, or their earlier death, resignation, disqualification or removal.	FOR EACH NOMINEE	19

2	Ratify the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2024.	FOR	20

3	Approve an amendment to our certificate of incorporation to effect a reverse stock split of our issued and outstanding common stock at a ratio of not less than 1-for-10 and not greater than 1-for-50, with the exact ratio and effective time of the reverse stock split, if any, to be determined in the sole discretion of the Board of Directors.	FOR	23

4	Approve, for purposes of the rules of the New York Stock Exchange, the potential issuance of more than 19.99% of our outstanding common stock upon the conversion of our outstanding convertible notes following an adjustment to the conversion rate of the convertible notes.	FOR	33

5	Approve, for purposes of the rules of the New York Stock Exchange, the potential issuance of more than 19.99% of our outstanding common stock upon the exercise of certain outstanding inducement grants.	FOR	36

6	Approve the amendment and restatement of the Getaround, Inc. 2022 Equity Incentive Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 4,000,000 shares and increase the annual evergreen percentage increase to the number of shares of common stock reserved for issuance thereunder.	FOR	38

7	Authorize and approve a repricing of certain stock options issued under the Getaround, Inc. Amended and Restated 2010 Stock Plan and 2022 Equity Incentive Plan that are held by eligible service providers.	FOR	48

We will also transact any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.

TABLE OF CONTENTS

			Page
About Getaround			1
General Information about the Annual Meeting			2
Board of Directors and Corporate Governance			9
Nominations Process and Director Qualifications			18
Proposal 1: Election of Directors			19
Proposal 2: Ratification of Selection of Independent Registered Public Accounting Firm			20
Proposal 3: Approval of the Reverse Stock Split Proposal			23
Proposal 4: Approval of the Convertible Note Share Issuance Proposal			33
Proposal 5: Approval of the Inducement Grant Share Issuance Proposal			36
Proposal 6: Approval of the Equity Incentive Plan Proposal			38
Proposal 7: Approval of the Stock Option Repricing Proposal			48
Security Ownership of Certain Beneficial Owners and Management			52
Executive Officers			55
Executive Compensation			56
Certain Relationships and Related Party Transactions			61
Report of the Audit Committee			65
Additional Information			66
Other Matters			67
Annex A: Certificate of Amendment			A-1
Annex B: Getaround, Inc. Amended and Restated 2022 Equity Incentive Plan			B-1

TABLE OF CONTENTS

ABOUT GETAROUND

Getaround is a global carsharing marketplace, powered by proprietary technology designed to make sharing cars simple, digital, on-demand, and automated. We reimagined the traditional car ownership model by empowering consumers, whom we refer to as our guests, to instantly and conveniently access safe, affordable and desirable cars they need while providing earnings potential to car owners who supply them, whom we refer to as our hosts. Our marketplace is designed to allow for a fully digital and contactless experience, without guests needing to wait in line at a car rental facility, manually fill out any paperwork, or meet anyone in person to exchange keys. Since launching in 2011, we have been focused on building and innovating our digital carsharing marketplace in the United States and internationally. As of March 31, 2024, our platform supports approximately 2.1 million unique guests and has approximately 75,000 active cars in more than 1,000 cities across 8 countries worldwide, including in the United States and across Europe.

We were incorporated in Delaware in September 2020 and formed as a special purpose acquisition company known as InterPrivate II Acquisition Corp. (“InterPrivate II”) for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. Legacy Getaround (as defined below) was incorporated in Delaware in 2009 and commenced operations in 2011. On December 8, 2022 (the “Closing Date”), we completed the acquisition of Legacy Getaround pursuant to an Agreement and Plan of Merger, dated as of May 11, 2022 (as amended, the “Merger Agreement”), by and among us, TMPST Merger Sub I Inc., a Delaware corporation and a wholly owned direct subsidiary of InterPrivate II, TMPST Merger Sub II LLC, a Delaware limited liability company and wholly owned direct subsidiary of InterPrivate II, and Getaround, Inc., a Delaware corporation (“Legacy Getaround”). We collectively refer to the transactions contemplated by the Merger Agreement as the “Business Combination.” In connection with the consummation of the Business Combination (the “Closing”), we changed our name from “InterPrivate II Acquisition Corp.” to “Getaround, Inc.”

TABLE OF CONTENTS

GENERAL INFORMATION ABOUT THE ANNUAL MEETING

The information provided in the “question and answer” format below addresses certain frequently asked questions but is not intended to be a summary of all matters contained in this Proxy Statement. Please read the entire Proxy Statement carefully before voting your shares.

Why did I receive these proxy materials?

Getaround is providing these proxy materials to you in connection with the Board’s solicitation of proxies for use at the Annual Meeting, which will be held on July 31, 2024. Stockholders are invited to attend the Annual Meeting and are requested to vote on the items of business described in this Proxy Statement.

All stockholders will have the ability to access the proxy materials via the internet, including this Proxy Statement and the Annual Report, as filed with the Securities and Exchange Commission (the “SEC”), beginning on July 3, 2024. This Proxy Statement and the Annual Report will be made available at www.proxyvote.com.

How do I attend the Annual Meeting?

The Annual Meeting will be a virtual meeting of stockholders, which will be conducted via live audio webcast. You are entitled to participate in the Annual Meeting only if you were a holder of our common stock as of the close of business on the Record Date or if you hold a valid proxy for the Annual Meeting.

You will be able to attend the Annual Meeting and submit your questions during the Annual Meeting by visiting www.virtualshareholdermeeting.com/GETR2024. You also will be able to vote your shares electronically at the Annual Meeting.

To participate in the Annual Meeting, you will need the control number included on your proxy card or on any additional voting instructions that accompanied your proxy materials. The live audio webcast will begin promptly at 10:00 a.m., Pacific Time. We encourage you to access the meeting prior to the start time. Online check-in will begin at 9:45 a.m., Pacific Time, and you should allow ample time for the check-in procedures.

How can I get help if I have trouble checking in or listening to the Annual Meeting online?

If you encounter any difficulties accessing the virtual meeting during the check-in or meeting time, please call the technical support number that will be posted on the virtual meeting log-in page.

Why a virtual-only online meeting?

Conducting the Annual Meeting virtually allows for remote participation and increases the opportunity for all stockholders to participate and communicate their views to a much wider audience. Stockholder rights are not affected. Additionally, the virtual meeting website uses software that verifies the identity of each participating stockholder and ensures during the question-and-answer portion of the meeting that they are granted the same rights they would have at an in-person meeting.

Our virtual Annual Meeting allows stockholders to submit questions and comments before and during the Annual Meeting by following the instructions that will be available on the virtual meeting website. Only questions pertinent to meeting matters or the Company and submitted in accordance with the rules of conduct for the Annual Meeting will be answered during the meeting, subject to time constraints. Questions that are substantially similar may be grouped and answered together to avoid repetition. The rules of conduct for the Annual Meeting will be available on the virtual meeting website.

TABLE OF CONTENTS

What proposals are scheduled to be voted on at the Annual Meeting and how does the Board recommend that I vote?

Proposal	Description	Vote Required	Board Vote Recommendation
1	Elect (i) the two Class I directors named as nominees in this Proxy Statement, each to serve until the annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2025, and (ii) the two Class II directors named as nominees in this Proxy Statement, each to serve until the annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2026, and, as to each, until their respective successors are elected and qualified, or their earlier death, resignation, disqualification or removal.	Plurality of Votes Cast for each Director Nominee	FOR EACH NOMINEE

2	Ratify the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2024.	Majority of Votes Cast	FOR

3	Approve an amendment to our certificate of incorporation to effect a reverse stock split of our issued and outstanding common stock at a ratio of not less than 1-for-10 and not greater than 1-for-50, with the exact ratio and effective time of the reverse stock split, if any, to be determined in the sole discretion of the Board of Directors, or the Reverse Stock Split Proposal.	Majority of Votes Cast	FOR

4	Approve, for purposes of the rules of the New York Stock Exchange, the potential issuance of more than 19.99% of our outstanding common stock upon the conversion of our outstanding convertible notes following an adjustment to the conversion rate of the convertible notes, or the Convertible Note Share Issuance Proposal.	Majority of Votes Cast	FOR

5	Approve, for purposes of the rules of the New York Stock Exchange, the potential issuance of more than 19.99% of our outstanding common stock upon the exercise of certain outstanding inducement grants, or the Inducement Grant Share Issuance Proposal.	Majority of Votes Cast	FOR

6	Approve the amendment and restatement of the Getaround, Inc. 2022 Equity Incentive Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 4,000,000 shares and increase the annual evergreen percentage increase to the number of shares of common stock reserved for issuance thereunder.	Majority of Votes Cast	FOR

7	Authorize and approve a repricing of certain stock options issued under the Getaround, Inc. Amended and Restated 2010 Stock Plan and 2022 Equity Incentive Plan that are held by eligible service providers, or the Stock Option Repricing Proposal.	Majority of Votes Cast	FOR

TABLE OF CONTENTS

We will also transact any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.

Could matters other than the proposals described in this Proxy Statement be decided at the meeting?

Our Amended and Restated Bylaws (the “Bylaws”) require that we receive advance notice of any proposal to be brought before the meeting by stockholders, and we have not received notice of any such proposals. If any other matter were to come before the meeting, the proxy holders appointed by the Board will have the discretion to vote on those matters for you.

Who can vote at the Annual Meeting?

Holders of our common stock at the close of business on June 27, 2024, or the Record Date, are entitled to receive notice of, to attend and participate, and to vote at the Annual Meeting. Each stockholder is entitled to one vote for each share of our common stock held as of the Record Date. As of the Record Date, there were 96,737,557 shares of common stock outstanding and entitled to vote. Stockholders are not permitted to cumulate votes with respect to the election of directors.

What is the difference between holding shares as a stockholder of record and as a beneficial owner?

Most Getaround stockholders hold their shares through a broker or other nominee rather than directly in their own name. As summarized below, there are some distinctions between shares held of record and those owned beneficially, which may affect how you can vote your shares.

Stockholder of Record (Shares Registered in Your Name). If, at the close of business on the Record Date, your shares were registered directly in your name with Continental Stock Transfer & Trust Company, our transfer agent, then you are considered the stockholder of record with respect to those shares, and this Proxy Statement was sent directly to you by Getaround. As the stockholder of record, you have the right to grant your voting proxy directly to Getaround as described in this Proxy Statement or to vote directly at the Annual Meeting.

Beneficial Owner (Shares Registered in the Name of a Broker or Other Nominee). If, at the close of business on the Record Date, your shares were held in a brokerage account, by a trustee or another nominee on your behalf, then you are considered the beneficial owner of shares held in “street name,” and this Proxy Statement was forwarded to you by your broker or nominee. As the beneficial owner of shares held in street name, you have the right to direct your broker, trustee or other nominee on how to vote the shares held in your account. Because a beneficial owner is not the stockholder of record, your broker, trustee or nominee has provided voting instructions or a voting instruction card to you to use in directing the broker, trustee or nominee on how to vote your shares. If you do not provide your broker, trustee or nominee with instructions on how to vote your shares, such broker, trustee, or nominee will be able to vote your shares only with respect to (i) the proposal related to the ratification of the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2024, and (ii) the Reverse Stock Split Proposal. For additional information, see “Will my shares be voted if I do not vote or instruct my nominee how to vote?” below.

How can I vote my shares at the Annual Meeting?

You may directly vote shares held in your name as the stockholder of record at the Annual Meeting. You may directly vote shares held beneficially in street name at the Annual Meeting only if you obtain a legal proxy and control number from the broker, trustee or nominee that holds your shares giving you the right to vote the shares. Even if you plan to attend the Annual Meeting, you should also submit your proxy or voting instructions as described below so that your vote will be counted if you later decide not to attend the meeting.

TABLE OF CONTENTS

How can I vote my shares without attending the Annual Meeting?

Whether you hold shares directly as the stockholder of record or beneficially in street name, you may direct how your shares are voted without attending the meeting. If you are a stockholder of record, you may vote by submitting a proxy by any of the methods specified below. If you hold shares beneficially in street name, you may vote by submitting voting instructions to your broker, trustee or nominee. For directions on how to vote, please refer to the instructions on your proxy card or, for shares held beneficially in street name, in the voting instructions provided by your broker, trustee or nominee.

•

Vote by Internet. Stockholders of record with internet access may vote at www.proxyvote.com by following the instructions at that site. The website address for internet voting is also provided on your proxy card. Your vote must be received by 11:59 p.m., Eastern Time, on July 30, 2024, to be counted. If you vote via the internet, you do not need to return a proxy card by mail. If you hold your shares beneficially in street name, please check the voting instruction card provided by your broker, trustee or nominee for internet voting availability and instructions.

•

Vote by Telephone. Stockholders of record may vote by telephone by dialing 1-800-690-6903 (the call is toll-free in the United States and Canada; toll charges apply to calls from other countries) and following the recorded instructions. You will be asked to provide the control number from your proxy card. Your vote must be received by 11:59 p.m., Eastern Time, on July 30, 2024, to be counted. If you vote by telephone, you do not need to return a proxy card by mail. If you hold your shares in street name, please check the voting instructions provided by your broker, trustee or nominee for telephone voting availability and instructions.

•

Vote by Mail. Stockholders of record who receive proxy materials by mail may submit proxies by completing, signing and dating their proxy cards and returning them promptly in the pre-addressed envelope provided so that it is received no later than July 30, 2024. Stockholders who hold shares beneficially in street name and who receive voting materials by mail from their brokers, trustees, or nominees may vote by mail by completing, signing, and dating the voting instruction cards provided and mailing them in the accompanying pre-addressed envelopes.

Your vote is important. Whether or not you plan to participate in the Annual Meeting, we urge you to vote by proxy to ensure that your vote is counted.

Can I change my vote or otherwise revoke my proxy?

You may change your vote at any time prior to the vote at the Annual Meeting. If you are the stockholder of record, you may change your vote by granting a new proxy by telephone, over the internet or by submitting a properly signed proxy card bearing a later date (which automatically revokes the earlier proxy). You may also revoke your proxy by providing a written notice of revocation to our Corporate Secretary at Getaround, Inc., Attn: Corporate Secretary, P.O. Box 24173, Oakland, California 94623 prior to your shares being voted, or by voting at the Annual Meeting. Attendance at the Annual Meeting without any other action will not cause your previously granted proxy to be revoked. For shares you hold beneficially in street name, you may change your vote by submitting new voting instructions to your broker, trustee or nominee, or, if you have obtained a legal proxy from your broker or nominee giving you the right to vote your shares, by voting at the Annual Meeting.

How many shares must be present or represented to conduct business at the Annual Meeting?

In order for business to be conducted at the Annual Meeting, a quorum must be present. The presence in person or by proxy of the holders of a majority of shares of common stock issued and outstanding and entitled to vote as of the Record Date will constitute a quorum at the Annual Meeting. Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, trustee or nominee) or if you attend the Annual Meeting through the live webcast and vote at the Annual Meeting. Both abstentions and broker non-votes will be counted for the purpose of determining the presence of a quorum. If there is no quorum, the holders of a majority of shares present virtually during the meeting or represented by proxy may adjourn the meeting to another date.

Will my shares be voted if I do not vote or instruct my nominee how to vote?

Stockholder of Record. If you do not submit a proxy or vote at the Annual Meeting, your shares will not be voted. If you indicate that you wish to vote as recommended by the Board or if you sign, date and return a proxy card but

TABLE OF CONTENTS

do not give specific voting instructions, then the proxy holders will vote your shares in the manner recommended by the Board on all matters presented in this proxy statement (i.e., “FOR” for each of Proposals 1 (each director) through 7) and in their discretion regarding any other matters properly presented for a vote at the Annual Meeting. As of the date of this proxy statement, we did not know of any proposals or matters to be raised at the Annual Meeting other than those presented in this proxy statement.

Beneficial Owner. If your shares are held in street name and you do not submit instructions to your broker, trustee or nominee on how to vote your shares, your broker, trustee or nominee may, under certain circumstances, vote your shares. A broker has discretionary authority to vote shares held for a beneficial owner on “routine” matters without instructions from the beneficial owner of those shares. On the other hand, absent instructions from the beneficial owner of such shares, a broker is not entitled to vote shares held for a beneficial owner on “non-routine” matters. The proposal related to the ratification of the appointment of dbbmckennon as our independent registered public accounting firm for the fiscal year ending December 31, 2023, and the Reverse Stock Split Proposal are considered “routine” matters. None of the other proposals are considered “routine” matters, and therefore your broker will not be able to vote on these proposals without your instructions.

What are broker non-votes?

A “broker non-vote” occurs when your broker, trustee or nominee has not received specific voting instructions from you with respect to shares held in street name and the broker, trustee or nominee does not have discretionary voting authority with respect to a proposal. Broker non-votes are counted as present for purposes of determining the presence or absence of a quorum for the transaction of business at the meeting. However, broker non-votes are not counted for purposes of all proposals and therefore have no effect on the outcome of these proposals, assuming that quorum is obtained.

How are abstentions treated?

Abstentions (i.e., shares present at the Annual Meeting and marked “abstain”) are counted for purposes of determining whether a quorum is present and have no effect on the outcome of the matters voted upon.

Who will tabulate the votes?

A representative of Broadridge Financial Solutions, Inc. will serve as the Inspector of Elections and will tabulate the votes at the Annual Meeting.

How may I access an electronic list of stockholders of record entitled to vote at the Annual Meeting?

We will make available an electronic list of stockholders of record as of the Record Date for inspection by stockholders for the ten (10) days prior to the meeting. To access the electronic list during this period, please send your request, along with proof of share ownership, by email to investors@getaround.com. You will receive confirmation of your request and instructions on how to view the electronic list. The list will also be available to stockholders at www.virtualshareholdermeeting.com/GETR2024 during the live webcast of the Annual Meeting.

What does it mean if I receive more than one proxy card?

If you receive more than one proxy card, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on each of the proxy cards to ensure that all of your shares are voted.

Who is paying for this proxy solicitation?

We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies online, by telephone or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We will also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.

Where can I find the voting results of the Annual Meeting?

We will announce preliminary voting results at the Annual Meeting. We will also disclose final voting results in a Current Report on Form 8-K that we expect to file with the SEC within four business days after the Annual Meeting.

TABLE OF CONTENTS

What if I have questions about my shares or need to change my mailing address on my stockholder account?

If you are a stockholder of record, you may contact our transfer agent, Continental Stock Transfer & Trust Company, by telephone at (800) 509-5586, through its website at www.continentalstock.com or by U.S. mail at 1 State Street, 30th Floor, New York, New York 10004, if you have questions about your Getaround shares or need to change your mailing address on your stockholder account.

I share an address with another stockholder, and we received only one paper copy of the proxy materials. How may I obtain an additional copy of the proxy materials?

The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders. This process is commonly referred to as “householding.”

Brokers with account holders who are Getaround stockholders may be householding our proxy materials. A single set of proxy materials may be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that it will be householding communications to your address, householding will continue until you are notified otherwise or until you notify your broker or Getaround that you no longer wish to participate in householding.

If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement and annual report, you may (1) notify your broker, (2) direct your written request to: Getaround, Inc., Attn: Corporate Secretary, P.O. Box 24173, Oakland, California 94623 or (3) contact our Investor Relations department by telephone at (415) 295-5725 or by email to investors@getaround.com. Stockholders who receive multiple copies of the proxy statement or annual report at their address and would like to request householding of their communications should contact their broker. In addition, we will promptly deliver, upon written or oral request to the address above, a separate copy of the annual report and proxy statement to a stockholder at a shared address to which a single copy of the documents was delivered.

What are the requirements to propose actions to be included in our proxy materials for our next annual meeting of stockholders, or for consideration at our next annual meeting?

Requirements for stockholder proposals to be considered for inclusion in our proxy materials for our next annual meeting:

Our Bylaws provide that stockholders may present proposals for inclusion in our proxy statement by submitting their proposals in writing to the attention of our Corporate Secretary at our principal executive office. Our current principal executive office is located at P.O. Box 24173, Oakland, California 94623. In addition, stockholder proposals must comply with the requirements of Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and related SEC regulations under Rule 14a-8 regarding the inclusion of stockholder proposals in company-sponsored proxy materials. In order to be included in our proxy materials for our next annual meeting, stockholder proposals must be received by our Corporate Secretary no later than March 7, 2025, and must otherwise comply with the requirements of Rule 14a-8 of the Exchange Act.

Requirements for stockholder nomination of director candidates and stockholder proposals to be presented at our next annual meeting:

Our Bylaws provide that stockholders may nominate persons for election to the Board and present proposals to be considered at an annual meeting by providing timely notice to our Corporate Secretary at the address of our principal executive office set forth above. To be timely for our next annual meeting, our Corporate Secretary must receive the written notice at our principal executive office:

•	not earlier than the close of business on April 2, 2025, and

•	not later than the close of business on May 2, 2025.

TABLE OF CONTENTS

If we hold our next annual meeting of stockholders more than 30 days before or more than 60 days after July 31, 2025 (the one-year anniversary date of the Annual Meeting), then notice of a nomination or stockholder proposal that is not intended to be included in our proxy statement must be received by our Corporate Secretary at our principal executive office:

•	not earlier than the close of business on the 120th day prior to such annual meeting, and

•	not later than the close of business on the later of (i) the 90th day prior to such annual meeting, or (ii) the 10th day following the day on which public announcement of the date of such annual meeting is first made.

A stockholder’s notice to the Corporate Secretary must set forth as to each matter the stockholder proposes to bring before the annual meeting the information required by the Bylaws. If a stockholder who has notified Getaround of such stockholder’s intention to present a proposal at an annual meeting does not appear to present such stockholder’s proposal at such meeting, Getaround does not need to present the proposal for vote at such meeting.

In addition, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must comply with the additional requirements of Rule 14a-19(b).

TABLE OF CONTENTS

BOARD OF DIRECTORS AND CORPORATE GOVERNANCE

Board Composition

Our business and affairs are managed under the direction of the Board. The Board currently consists of eight members. The Chairperson of the Board is Jason Mudrick and our Board has determined that five of our directors are independent within the meaning of the independence requirements of the New York Stock Exchange (“NYSE”). In accordance with our Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), the Board is divided into three classes with staggered three-year terms. At each annual meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of election and qualification until the third annual meeting following their election. Our directors are currently divided among the three classes as follows: the Class I director is Bruno Bowden; the Class II directors are Eduardo Iniguez and Ravi Narula; and the Class III directors are Jason Mudrick, Nikul Patel, Neil Salvage, Qais Sharif and Sam Zaid.

Messrs. Bowden and Narula, whose terms as Class I and II directors, respectively, end at the Annual Meeting, have been nominated to serve as Class I directors for a three-year term expiring at our annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2025. Mr. Iniguez, whose term as a Class II director expires at the Annual Meeting, and Mr. Mudrick, who has conditionally agreed to resign as a Class III director prior to the opening of the polls at the Annual Meeting, have been nominated to serve as Class II directors for a three-year term expiring at our annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2026. Messrs. Patel, Salvage, Sharif and Zaid currently serve as Class III directors, and their terms will expire at our annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2024.

In connection with the closing of the Third A&R Note in January 2024, as described below under the heading “Certain Relationships and Related Party Transactions — Investments by Mudrick Capital Management,” we agreed, pursuant to the A&R Incremental Subscription Agreement, to appoint Mr. Mudrick as a Class III director. In addition, in connection with the closing of the Fifth A&R Note in April 2024, we agreed, pursuant to the Second A&R Incremental Subscription Agreement, that Mudrick Capital Management would be entitled to identify and recommend to the Board three independent director candidates, and, assuming each such candidate (i) is reasonably acceptable to a majority of the other directors and (ii) meets the independence requirements of the New York Stock Exchange (each, an “Independent Director Candidate”), the Board will appoint each such Independent Director Candidate to the Board as a Class III director and at least two of such Independent Director Candidates to the compensation committee and the nominating and corporate governance committee of the Board. Effective May 6, 2024, the Board appointed Messrs. Patel, Salvage and Sharif as Class III directors. We further agreed that, following the appointment of the Independent Director Candidates as Class III directors, Mr. Mudrick would serve as a Class II director. See “Certain Relationships and Related Party Transactions — Investments by Mudrick Capital Management” for additional information.

The following table sets forth certain information, including ages as of June 1, 2024, with respect to our directors who we expect to continue in office after the Annual Meeting, including the four nominees for election at the Annual Meeting:

Name

Age

Director Since

Independent

Audit

Compensation

Nominating and

Corporate

Governance

Class I Directors – Nominees for Election at the Annual Meeting

Bruno Bowden

December 2022

Chair

Ravi Narula⁽¹⁾

December 2022

Chair

Class II Directors – Nominees for Election at the Annual Meeting

Eduardo Iniguez

February 2024

Jason Mudrick⁽²⁾

January 2024

Class III Directors – Continuing in Office

Nikul Patel

May 2024

Neil Salvage

May 2024

Chair

Qais Sharif

May 2024

Sam Zaid

December 2022

(1)	Currently a Class II director.

(2)	Currently a Class III director.

TABLE OF CONTENTS

The following is a brief biography of each nominee and each director whose term will continue after the Annual Meeting.

Class I Director Nominees

Bruno Bowden. Mr. Bowden has served as a member of the Board since the Closing. Since December 2020, Mr. Bowden has served as a Managing Partner and co-founder of Grep VC, a venture capital firm investing in new technologies in AI and robotics. Prior to Grep VC, he served as an Engineering Manager at Aurora Innovation, a self-driving vehicle technology company, from May 2017 to September 2018 and as an Equity Partner at Data Collective, a venture capital firm investing in entrepreneurs building Big Data companies, from 2012 to 2017. Prior to that, he served as Engineering Manager at Google, Inc. for over seven years. Mr. Bowden holds a B.A. in Computer Science from the University of Cambridge. We believe that Mr. Bruno is qualified to serve as a member of the Board because of his extensive experience in the venture capital and technology industries.

Ravi Narula. Mr. Narula has served as a member of the Board since the Closing. Mr. Narula has served as the Chief Financial Officer of Certinia Inc., a provider of customer-centric business applications across finance, services, and customer success teams, from June 2021 through October 2023. He previously served as Chief Financial Officer of Ooma, Inc., a smart communications platform for businesses and consumers, from December 2014 to June 2021. Mr. Narula also served as a director of Ooma, Inc. from January 2021 to June 2021. Prior to joining Ooma, he served in different finance roles at Gigamon Inc., a network traffic management software provider, including the role of Chief Accounting Officer from April 2013 to November 2014, and Vice President and Corporate Controller from April 2012 to November 2014. Mr. Narula worked at BigBand Networks, Inc., a digital video networking company, from July 2005 to January 2012, and served as its Chief Financial Officer from May 2010 to January 2012. Prior to joining BigBand, Mr. Narula served as the Director of Financial Governance at Borland Software Corporation, a software company, and was a Senior Manager at Deloitte & Touche, an international accounting firm. Mr. Narula holds a Bachelor of Commerce degree from the University of Garhwal, India and is a licensed CPA (inactive) in the state of California and in Canada. We believe Mr. Narula is qualified to serve as a member of the Board because of his financial expertise, including his several years of experience as chief financial officer and comparable financial roles of publicly traded and privately held companies, and his financial and accounting knowledge.

Class II Director Nominees

Eduardo Iniguez. Mr. Iniguez has served as our Chief Executive Officer and as a member of the Board since February 2024. He previously served our Vice President of Risk & Strategy from May 2023, when we acquired certain assets from HyreCar, Inc., his former employer, to November 2023. Prior to rejoining Getaround, Mr. Iniguez served as the Chief Financial Officer of Silvus Technologies, a developer of advanced multiple-input, multiple-output communication systems, from November 2023 to February 2024. Prior to that, Mr. Iniguez served in various capacities at HyreCar, Inc. from May 2022 to May 2023, including serving as its interim Chief Executive Officer from December 2022 to May 2023. From September 2018 to May 2022, Mr. Iniguez was the Vice President of Corporate Finance at AllClear Aerospace & Defense, an aerospace distribution company, in which role Mr. Iniguez served as the Chief Financial Officer for one of the company’s joint ventures while overseeing the company’s finance and accounting functions. Mr. Iniguez received his Master of Business Administration and Bachelor of Science from the University of Southern California. We believe Mr. Iniguez is qualified to serve as a member of the Board because of his knowledge of the Company, HyreCar and the carsharing industry and his extensive experience in operational and financial management at other technology companies.

Jason Mudrick. Mr. Mudrick has served as a member of the Board since January 2024 and was appointed Chairman of the Board in February 2024. Mr. Mudrick is the founder and Chief Investment Officer of Mudrick Capital, an investment firm that specializes in long and short investments in distressed credit. Mudrick Capital was founded in 2009. Before founding Mudrick Capital, Mr. Mudrick served as Managing Director and Portfolio Manager of the Contrarian Equity Fund, a fund specializing in post-restructured equities. Mr. Mudrick has previously served on multiple creditors’ committees and boards of directors for several public and privately held companies. Mr. Mudrick holds his Bachelor of Arts degree in Political Science from the University of Chicago and his Juris Doctorate from Harvard Law School. We believe Mr. Mudrick is qualified to serve as a member of the Board because of his financial sophistication, capital market expertise, and extensive experience serving as a director of, or investing in, a number of privately and publicly held companies.

TABLE OF CONTENTS

Continuing Directors

Nikul Patel. Mr. Patel has served as a member of the Board since May 2024. Mr. Patel is the Founder and CEO of LoanGlide, Inc., an embedded financing platform for personal loans. Prior to LoanGlide, Mr. Patel held several senior management positions at LendingTree, Inc., including Chief Strategy Officer, Chief Operating Officer, and Chief Product Officer. Prior to joining LendingTree, Mr. Patel held various leadership positions at Bills.com, Inc. and Intel Corporation. Mr. Patel serves as a director of Data Axle, Inc., and Skyline Champion Corporation. He holds an MBA from the Wharton School of the University of Pennsylvania, an MS in Computer Engineering from Florida Atlantic University, and a BS in Electronics and Communication Engineering from Gujarat University. We believe Mr. Patel is qualified to serve as a member of the Board because of his extensive senior leadership and executive experience in the technology industries.

Neil Salvage. Mr. Salvage has served as a member of the Board since May 2024. Mr. Salvage previously served as Chief Revenue Officer and then President and Chief Operating Officer of LendingTree where he was responsible for overall company revenue and then management of the company’s day -to-day operations. Prior to LendingTree, he held senior roles at CBS Corporation, CityGrid Media, LLC, and YellowPages.com. He holds an MA in Computer Resources and Information Management from Webster University and a BS in Business Management from the University of South Carolina. We believe Mr. Salvage is qualified to serve as a member of the Board because of his management experience with knowledge and perspective on the Company’s daily operating challenges gained from experience as an operating executive in the financial and information technology industries.

Qais Sharif. Mr. Sharif has served as a member of the Board since May 2024. Mr. Sharif has held various global management positions at Visteon Corporation, where he currently serves as Senior Vice President and General Manager of the Americas and Energy Storage Solutions. Prior to Visteon, he was Vice President, IT & Mobile USA Sales and Marketing, for LG Electronics Inc.’s consumer and automotive display markets. Previous to that, he held global senior leadership roles at TE Connectivity, Sharp Microelectronics and Toshiba. He holds a BS in Electrical Engineering from Southern Illinois University. We believe Mr. Sharif is qualified to serve as a member of the Board because of his experience in leadership positions at global companies in the consumer and business products industries.

Sam Zaid. Mr. Zaid is a co-founder of Getaround and has served as a member of the Board since the Closing, and previously served as our Chief Executive Officer and as Chairman of the Board from the Closing until February 2024. Prior to the Closing, Mr. Zaid served as the Chief Executive Officer of Legacy Getaround from January 2022 until the Closing and from 2010 until December 2020, and as Executive Chairman of Legacy Getaround from December 2020 until December 2021. Before Getaround, Mr. Zaid founded and served as Chief Executive Officer of 360pi, a price intelligence platform for online retailers that was acquired by MarketTrack in 2017. Mr. Zaid also founded and served as Chief Executive Officer of Apption, an enterprise software consultancy specializing in big data analytics and Artificial Intelligence that he founded in 2004. Mr. Zaid has been named an E&Y Entrepreneur of the Year, a Microsoft Code Award winner, and was a Google Scholarship recipient. Mr. Zaid studied Engineering Physics at Queen’s University in Canada, graduating with First-class honors, and Artificial Intelligence & Robotics through the Singularity University Graduate Studies Program.

Corporate Governance Guidelines and Code of Business Conduct and Ethics

Getaround is strongly committed to good corporate governance practices. These practices provide an important framework within which the Board and our management can pursue our strategic objectives for the benefit of our stockholders.

Our Corporate Governance Guidelines set forth our policies and procedures related to corporate governance and cover topics including director qualifications and responsibilities, board composition and management, and succession planning. Our Corporate Governance Guidelines are available without charge on the investor relations portion of our website at getaround.com.

We have adopted a written code of business conduct and ethics that applies to our directors and officers, employees, independent contractors and consultants, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code is posted on the investor relations portion of our website at getaround.com. In addition, we intend to post on our website all disclosures that are required by law or the NYSE listing standards concerning any amendments to, or waivers from, any provision of the code.

TABLE OF CONTENTS

Board Leadership Structure

Our Corporate Governance Guidelines provide that the Board may select a Chairperson in the manner and on the criteria that the Board determines appropriate at the time of selection. In the event that our Chairperson is not independent, the independent directors of the Board, upon the recommendation of the nominating and corporate governance committee, will designate a lead independent director by a majority vote of the independent directors, which lead independent director shall have the responsibilities set forth in our Corporate Governance Guidelines. The independent members of the Board also meet in executive session without management, which we believe enhances the benefit of having the perspective of independent directors. The independent directors may choose a presiding director for such executive sessions by majority vote for each session.

The Board is currently led by its Chairperson, Jason Mudrick. We currently separate the roles of Chief Executive Officer and Chairperson of the Board in recognition of the differences between the two roles. The Chief Executive Officer is responsible for setting the strategic direction for Getaround and the day-to-day leadership and performance of the Company, while the Chairperson provides guidance to the Chief Executive Officer and presides over meetings of the full Board. We believe this separation of responsibilities provides a balanced approach to managing the Board and overseeing the Company.

Although we currently do not have a lead independent director, the Board has concluded that our current leadership structure is appropriate at this time. However, the Board will continue to periodically review our leadership structure and may make such changes in the future as it deems appropriate.

Board Role in Risk Oversight

One of the key functions of the Board is informed oversight of our risk management process. Although the Board does not have a standing risk management committee, it administers this oversight function directly through the board of directors as a whole, as well as through its standing committees that address risks inherent in their respective areas of oversight. Areas of focus include economic, operational, financial (accounting, credit, investment, liquidity and tax), competitive, legal, regulatory, cybersecurity, privacy, compliance and reputational risks. The risk oversight responsibility of the Board and its committees is supported by our management reporting processes, which are designed to provide visibility to the Board and to our personnel who are responsible for risk assessment and information about the identification, assessment and management of critical risks, and our management’s risk mitigation strategies.

Our audit committee is responsible for reviewing and discussing our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including its investment policies and its guidelines and policies with respect to risk assessment and risk management. The audit committee also monitors compliance with legal and regulatory requirements and assists the Board in fulfilling its oversight responsibilities with respect to risk management. The nominating and corporate governance committee assesses risks related to our overall corporate governance practices, including board and committee composition, board size and structure and the independence of the Board, as well as succession planning, and monitors the effectiveness of our governance guidelines. The compensation committee reviews with management our major compensation-related risk exposures and the steps management has taken to monitor and control such exposures, and assesses whether any of our compensation policies and practices create risks that are reasonably likely to have a material adverse effect on the Company.

We believe this division of responsibilities is an effective approach for addressing the risks we face and that our board leadership structure supports this approach.

Director Independence

Our common stock is listed on the NYSE. Under the listing requirements and rules of the NYSE, independent directors must comprise a majority of the Board. In addition, the rules of the NYSE require that, subject to specified exceptions, each member of a listed company’s audit, compensation and nominating and corporate governance committees be independent. Under the rules of the NYSE, a director will only qualify as an “independent director” if the Board determines that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Compensation committee members must not have a relationship with us that is material to the director’s ability to be independent from management in connection with the duties of a compensation committee member. Additionally, audit committee members must also satisfy the

TABLE OF CONTENTS

independence criteria set forth in Rule 10A-3 under the Exchange Act. To be considered independent for purposes of Rule 10A-3, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors or any other board committee accept, directly or indirectly, any consulting, advisory or other compensatory fee from the listed company or any of its subsidiaries or be an affiliated person of the listed company or any of its subsidiaries.

The Board has undertaken a review of its composition, the composition of its committees, and the independence of each director and considered whether any director has a material relationship with us that could compromise his ability to exercise independent judgment in carrying out his responsibilities as required by the rules of the NYSE. Based upon information requested from and provided by each director concerning such director’s background, employment and affiliations, including family relationships, the Board determined that Messrs. Bowden, Narula, Patel, Salvage and Sharif, representing five of our eight directors, are “independent directors” as defined under current rules and regulations of the SEC and the listing standards of the NYSE. In making these determinations, the Board considered the current and prior relationships that each non-employee director has with the Company and all other facts and circumstances that the Board deemed relevant in determining their independence, including the beneficial ownership of our securities by each non-employee director and the transactions involving them described under “Certain Relationships and Related Party Transactions” below.

Committees of the Board

The Board has three standing committees — an audit committee, a compensation committee and a nominating and corporate governance committee — each of which have the composition and the responsibilities described below. Each of these committees operates under a written charter that satisfies the applicable listing standards of the NYSE, copies of which are available on the investor relations portion of our website at getaround.com. Members serve on these committees until their resignation or until otherwise determined by the Board. The Board may establish other committees as it deems necessary or appropriate from time to time. The reference to our website address does not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be a part of this prospectus.

Audit Committee

Our audit committee consists of Messrs. Bowden, Narula and Patel, with Mr. Narula serving as chair. Rule 10A-3 of the Exchange Act and the NYSE listing standards require that our audit committee be composed entirely of independent members. The Board has determined that each of Messrs. Bowden, Narula and Patel meets the definition of “independent director” for purposes of serving on the audit committee under Rule 10A-3 of the Exchange Act and the NYSE listing standards and also meets the financial literacy requirements of the NYSE listing standards. In addition, the Board has determined that Mr. Narula qualifies as an “audit committee financial expert” within the meaning of the SEC regulations.

The primary purpose of the audit committee is to discharge the responsibilities of the Board with respect to our corporate accounting and financial reporting processes, systems of internal control and financial statement audits and to oversee our independent registered public accounting firm. The principal functions of the audit committee include, among other things:

•	helping the Board oversee our corporate accounting and financial reporting processes;

•	managing the selection, engagement, qualifications, independence, and performance of a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;

•	reviewing and discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent accountants, our interim and year-end operating results;

•	obtaining and reviewing a report by the independent registered public accounting firm at least annually that describes our internal quality control procedures, any material issues with such procedures and any steps taken to deal with such issues when required by applicable law;

•	establishing procedures for employees to submit concerns anonymously about questionable accounting or audit matters;

•	overseeing our policies on risk assessment and risk management;

•	overseeing compliance with our code of business conduct and ethics;

TABLE OF CONTENTS

•	reviewing related person transactions; and

•	approving or, as required, pre-approving audit and permissible non-audit services to be performed by the independent registered public accounting firm.

Compensation Committee

Our compensation committee consists of Messrs. Bowden, Salvage and Sharif, with Mr. Bowden serving as chair. The Board has determined that each of Messrs. Bowden, Salvage and Sharif meets the definition of “independent director” for purposes of serving on the compensation committee under the NYSE listing standards, including the heightened independence standards for members of a compensation committee.

The primary purpose of our compensation committee is to discharge the responsibilities of the Board in overseeing our compensation policies, plans and programs and to review and determine the compensation to be paid to our executive officers, directors and other senior management, as appropriate. The principal functions of the compensation committee include, among other things:

•	reviewing, approving and determining, or making recommendations to the Board regarding, the compensation of our chief executive officer, other executive officers and senior management;

•	reviewing, evaluating and recommending to the Board succession plans for our executive officers;

•	reviewing and recommending to the Board the compensation paid to our non-employee directors;

•	administering our equity incentive plans and other benefit programs;

•	reviewing, adopting, amending and terminating incentive compensation and equity plans, severance agreements, profit sharing plans, bonus plans, change-of-control protections and any other compensatory arrangements for our executive officers and other senior management;

•	administering our compensation recovery policy, which allows us to recover incentive-based compensation awarded or paid to applicable officers in the event of a financial restatement or misconduct; and

•	reviewing and establishing general policies relating to compensation and benefits of our employees, including our overall compensation philosophy.

Nominating and Corporate Governance Committee

Our nominating and corporate governance committee consists of Messrs. Patel, Salvage and Sharif, with Mr. Salvage serving as chair. The Board has determined that each of Messrs. Patel, Salvage and Sharif meets the definition of an “independent director” under the NYSE listing standards.

Our nominating and corporate governance committee is responsible for, among other things:

•	identifying and evaluating candidates, including the nomination of incumbent directors for reelection and nominees recommended by stockholders, to serve on the Board;

•	considering and making recommendations to the Board regarding the composition and chairmanship of the committees of the Board;

•	instituting plans or programs for the continuing education of the Board and the orientation of new directors;

•	developing and making recommendations to the Board regarding corporate governance guidelines and matters;

•	overseeing our corporate governance practices;

•	overseeing periodic evaluations of the Board’s performance, including committees of the Board; and

•	contributing to succession planning.

Policy Against Hedging

Under the terms of our insider trading policy, our directors, officers, employees and contractors (and their respective family members and affiliated entities, such as venture capital funds) are prohibited from engaging in hedging or monetization transactions involving our securities, such as prepaid variable forward contracts, equity swaps, collars or exchange funds. In addition, such persons may not hold our securities in a margin account or pledge our securities as collateral for a loan unless the pledge has been approved by our designated compliance officer.

TABLE OF CONTENTS

Board and Committee Meetings and Attendance

The Board and its committees meet regularly throughout the year and also hold special meetings and act by written consent from time to time. During the fiscal year ended December 31, 2023, the Board met 15 times; the audit committee met 6 times; the compensation committee met 6 times; and the nominating and corporate governance committee met 2 times.

During the fiscal year ended December 31, 2023, each member of the Board attended at least 75% of the aggregate of all meetings of the Board and of all meetings of committees of the Board on which such member served that were held during the period in which such director served.

While we do not have a formal policy regarding attendance by members of the Board at our annual meetings of stockholders, each director is encouraged to attend. We did not hold an annual meeting of stockholders in 2023 in respect of our fiscal year ended December 31, 2022, due to the delay in finalizing our financial statements for that fiscal year. See “Proposal 1 – Election of Directors.”

Communications with Directors

Stockholders and other interested parties may communicate with the Board, non-management members of the Board as a group, a committee of the Board or a specific member of the Board (including our Chairperson or lead independent director, if any) by writing to the Board, c/o General Counsel, Getaround, Inc., P.O. Box 24173, Oakland, California 94623. All communications are reviewed by the General Counsel or his designee and, if appropriate, forwarded to the Chairperson of the Board or to the member or members of the Board to whom the communications are addressed.

Director Compensation

Non-Employee Director Compensation Table for Fiscal Year 2023

The following table sets forth information concerning the compensation of our non-employee directors for the year ended December 31, 2023.

Name	Fees Earned or Paid in Cash ($)⁽¹⁾	Stock Awards ($)⁽²⁾⁽³⁾	All Other Compensation ($)	Total ($)
Bruno Bowden	44,837	16,667	—	61,504
Ahmed M. Fattouh⁽⁴⁾	—	16,667	—	16,667
Ravi Narula	44,837	66,667	—	111,504
Jeffrey Russakow⁽⁵⁾	—	90,500	486,661⁽⁶⁾	577,161
Neil S. Suslak⁽⁷⁾	—	12,500	—	12,500

(1)	Pursuant to our non-employee director compensation policy, each director (other than Dr. Russakow) was eligible to earn a cash retainer for service during the year ended December 31, 2023.

(2)

The amount reported in this column reflects the aggregate grant date fair value for financial statement reporting purposes of RSUs granted during the fiscal year ended December 31, 2023, as determined in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification Topic 718 (“FASB ASC Topic 718”). This amount reflects our accounting expense for these RSUs and does not represent the actual economic value that may be realized by the director. There can be no assurance that the amount will ever be realized. For the assumptions used in valuing the award, please see Note 15 – Stock- Based Compensation to our consolidated financial statements included in the Annual Report.

(3)

Each of the directors received an RSU award on August 8, 2023, consisting of: 33,333 RSUs (Mr. Bowden); 33,333 RSUs (Mr. Fattouh); 133,333 RSUs (Mr. Narula); 181,000 RSUs (Dr. Russakow); and 25,000 RSUs (Mr. Suslak). The RSUs granted to Messrs. Bowden, Fattouh and Narula were granted under our non- employee director compensation policy, as further described below, and vested in full on December 9, 2023. The RSUs granted to Dr. Russakow were granted in connection with the service arrangement under his consulting agreement, as further described below, and will vest as follows: one-third of the RSUs vesting on August 15, 2023, and 1/4th of the RSUs vesting on the same day of every third month thereafter, subject to the holder’s continuous service through each vesting date. The RSUs granted to Mr. Suslak, which were granted under our non-employee director compensation policy, did not vest and were forfeited upon his resignation from the Board in October 2023.

Our non-employee directors held the following number of RSUs as of December 31, 2023:

Name			RSUs Outstanding
Bruno Bowden			33,333
Ahmed M. Fattouh			33,333
Ravi Narula			133,333
Jeffrey Russakow			341,126
Neil S. Suslak			—

(4)	Mr. Fattouh resigned from the Board effective as of January 19, 2024.

TABLE OF CONTENTS

(5)	Dr. Russakow resigned from the Board effective as of April 28, 2024.

(6)

We entered into a consulting agreement with Dr. Russakow effective as of November 1, 2021, as amended effective as of July 5, 2022, pursuant to which we agreed to pay Dr. Russakow $50,000 per month for services rendered under the consulting agreement, resulting in a total amount of $486,661 paid during fiscal year 2023.

(7)	Mr. Suslak resigned from the Board effective as of October 11, 2023.

Non-Employee Director Compensation Arrangements

The Board has adopted a non-employee director compensation policy designed to attract and retain high quality non-employee directors (“Outside Directors”) by providing competitive compensation and to align their interests with the interests of our stockholders through equity awards. In connection with the appointment of the Independent Director Candidates described above, we expect that our Board will adopt a new non-employee director compensation policy.

Specifically, the current policy provides for the following annual cash retainers, which are payable quarterly in arrears and pro-rated for partial quarters of service:

Annual Board Member Service Retainer

•	All Outside Directors: $35,000

•	Lead Independent Director: $7,500 (in addition to above)

Annual Committee Member Service Retainer

•	Member of the Audit Committee: $10,000

•	Member of the Compensation Committee: $7,500

•	Member of the Nominating and Corporate Governance Committee: $5,000

Annual Committee Chair Service Retainer (in lieu of Annual Committee Member Service Retainer)

•	Chairperson of the Audit Committee: $20,000

•	Chairperson of the Compensation Committee: $15,000

•	Chairperson of the Nominating and Corporate Governance Committee: $10,000

As described below, Outside Directors will also receive equity awards under the 2022 Equity Incentive Plan annually and will receive awards upon their initial appointment to the Board, as follows:

•

Upon initial election or appointment to the Board, a stock option or restricted stock unit award, as determined by the Board, with a grant date value of $300,000, which will vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to such director’s continuous service through each applicable vesting date; and

•

At each annual stockholder meeting following such director’s appointment to the Board and such director’s service on the Board for a minimum of six months, an additional stock option or restricted stock unit award, as determined by the Board, with a grant date value of $150,000, which will vest in full upon the earlier of the first anniversary of the date of grant or the day prior to the next annual stockholder meeting, subject to such director’s continuous service through the applicable vesting date.

Notwithstanding the foregoing, for each Outside Director who remains in continuous service as a member of the Board until immediately prior to the consummation of a “change in control” (as defined in the 2022 Equity Incentive Plan), any unvested portion of an equity award granted in consideration of such director’s service as a member of the Board will vest in full immediately prior to, and contingent upon, the consummation of such change in control.

The Board will also have discretion to grant additional equity awards to certain Outside Directors for services to us that exceed the standard expectations for an Outside Director or for other circumstances determined to be appropriate by the Board. We will also reimburse directors for their reasonable out-of-pocket expenses in connection with attending board and committee meetings.

TABLE OF CONTENTS

Director Compensation Agreement

We entered into a consulting agreement with Dr. Russakow effective as of November 1, 2021, as amended effective as of July 5, 2022. Pursuant to the consulting agreement, we agreed to pay Dr. Russakow $50,000 per month for services rendered under the consulting agreement. Further, we granted Dr. Russakow an award of restricted stock units covering 181,000 shares of common stock on August 8, 2023. The consulting agreement may be terminated by either party at any time upon 10 business days’ written notice or, if either party defaults in the performance of the consulting agreement or materially breaches any of its obligations under the consulting agreement, the non-breaching party may terminate the consulting agreement immediately if the breaching party fails to cure the breach within 3 business days of receiving written notice of the breach. Effective April 28, 2024, the consulting agreement was terminated in connection with Dr. Russakow’s resignation from the Board.

TABLE OF CONTENTS

NOMINATIONS PROCESS AND DIRECTOR QUALIFICATIONS

Process for Nominations to the Board

The nominating and corporate governance committee is responsible for recommending to the Board nominees for election to the Board at each annual meeting of stockholders and for identifying one or more candidates to fill any vacancies that may occur on the Board. New candidates may be identified through recommendations from existing directors or members of management, consultants or third-party search firms, discussions with other persons who may know of suitable candidates to serve on the Board, and stockholder recommendations. Evaluations of prospective candidates typically include a review of the candidate’s background and qualifications by the nominating and corporate governance committee, interviews with the committee as a whole, one or more members of the committee, or one or more other Board members, and discussions within the committee and the full Board. In the case of incumbent directors whose terms of office are set to expire at the annual meeting of stockholders, the nominating and corporate governance committee reviews these directors’ overall service to us during their terms, including the number of meetings attended, level of participation, quality of performance and any other relationships and transactions that might impair the directors’ independence. The nominating and corporate governance committee then recommends candidates to the full Board, with the full Board selecting the candidates to be nominated for election by the stockholders or to be appointed by the Board to fill a vacancy.

The nominating and corporate governance committee will also consider director candidates proposed by stockholders as well as recommendations from other sources. Any stockholder who wishes to recommend a prospective candidate for the Board for consideration by the nominating and corporate governance committee may do so by submitting the name and qualifications of the prospective candidate in writing to the following address: Getaround, Inc., Attn: Corporate Secretary, P.O. Box 24173, Oakland, California 94623. Any such submission must also describe the experience, qualifications, attributes and skills that make the prospective candidate a suitable nominee for the Board, as well as other information set forth in our Corporate Governance Guidelines. Our Bylaws set forth the requirements for direct nomination by a stockholder of persons for election to the Board.

Additional information regarding the process for properly submitting stockholder nominations for candidates for nomination to the Board is set forth above under “General Information about the Annual Meeting.”

Director Qualifications

With the goal of developing an experienced and highly qualified board of directors, with a diverse background and skill set that contributes to the total mix of viewpoints and experience represented on the Board, our nominating and governance committee is responsible for developing and recommending to the Board the desired qualifications, expertise and characteristics of members of the Board, including any specific minimum qualifications that the committee believes must be met by a committee-recommended nominee for membership on the Board and any specific qualities or skills that the committee believes are necessary for one or more of the members of the Board to possess.

Because the identification, evaluation and selection of qualified directors is a complex and subjective process that requires consideration of many intangible factors, and will be significantly influenced by the particular needs of the Board from time to time, the Board has not adopted a specific set of minimum qualifications, qualities or skills that are necessary for a nominee to possess, other than those that are necessary to meet U.S. legal, regulatory and NYSE listing requirements and the provisions of our Certificate of Incorporation and Bylaws, our Corporate Governance Guidelines and the charters of the committees of the Board. When considering nominees, our nominating and governance committee may take into consideration many factors including, among other things, a candidate’s independence, character, integrity, judgment diversity, professional achievements, skills, financial and other areas of expertise, breadth of experience, knowledge about our business or industry and ability to devote adequate time and effort to responsibilities of the Board in the context of its existing composition. The Board does not have a formal policy with respect to diversity and inclusion; however, it affirms the value placed on diversity within the Company. Through the nomination process, our nominating and governance committee seeks to promote board membership that reflects a diversity of business experience, expertise, viewpoints, personal backgrounds and other characteristics that are expected to contribute to the overall effectiveness of the Board. Accordingly, our nominating and governance committee may consider such factors as gender, race, ethnicity, differences in professional background, experience at policy-making levels in business, finance and technology and other areas, education, skill and other individual qualities and attributes. The brief biographical description of each director set forth above under “Board of Directors and Corporate Governance—Board Composition” includes the primary individual experience, qualifications, attributes and skills of each of our directors that led to the conclusion that each director should serve as a member of the Board at this time.

TABLE OF CONTENTS

PROPOSAL 1:

ELECTION OF DIRECTORS

The Board currently has eight members and, in accordance with our Certificate of Incorporation, is divided into three classes, with the classes as nearly equal in number as possible, and with each class typically serving staggered three-year terms. One class is elected each year at the annual meeting of stockholders for a term of three years to succeed the same class whose term is then expiring. However, because we did not hold an annual meeting of stockholders in 2023 in respect of our fiscal year ended December 31, 2022, due to the delay in finalizing our financial statements for that fiscal year, the Board has nominated directors for re-election at the Annual Meeting to serve in both Class I and Class II. Each of the nominees listed below has been selected by the Board as a nominee in accordance with the recommendation of the nominating and corporate governance committee. Each nominee, if elected, will hold office until the annual meeting of stockholders at which such director’s term expires and until the election and qualification of such director’s successor, or until such director’s earlier death, resignation, disqualification or removal.

Nominees for Election

The Board has nominated Messrs. Bowden and Narula for election as Class I directors and Messrs. Iniguez and Mudrick for election as Class II directors at the Annual Meeting. If elected, each of Messrs. Bowden and Narula will serve as Class I directors until the annual meeting of stockholders in respect of our fiscal year ending December 31, 2025, and Messrs. Iniguez and Mudrick will serve as Class II directors until the annual meeting of stockholders to be held in respect of our fiscal year ending December 31, 2026, or until their respective successors are elected and qualified, or their earlier death, resignation, disqualification or removal. For information concerning the nominees, see the section titled “Board of Directors and Corporate Governance.”

Unless you direct otherwise through your proxy voting instructions, the persons named as proxies will vote all proxies received “FOR” the election of each nominee. If any nominee is unable or unwilling to serve at the time of the Annual Meeting, the persons named as proxies may vote for a substitute nominee chosen by the present Board. In the alternative, the proxies may vote only for the remaining nominees, leaving a vacancy on the Board. The Board may fill such vacancy at a later date or reduce the size of the Board. Each of the nominees is a current member of our Board and has consented to serve if elected, and we have no reason to believe that any of the nominees will be unwilling or unable to serve if elected as a director.

Required Vote

Our Bylaws provide that the election of directors requires a plurality of the votes of the shares present virtually or represented by proxy at the Annual Meeting and entitled to vote on the election of directors. Under this voting standard, once a quorum has been established, the nominees who receive the largest number of votes are elected as directors up to the maximum number of directors to be elected at the meeting. As described above, the Board has nominated two persons for election as Class I Directors and two persons for election as Class II Directors at the Annual Meeting and, as a result, the two nominees receiving the highest number of votes in each director class being elected at the Annual Meeting will be elected, even if these votes do not constitute a majority of the votes cast. Stockholders cannot vote for a greater number of persons than the four nominees named. Only votes cast “FOR” a nominee will be counted in the election of directors. Votes that are “WITHHELD” with respect to one or more nominees will result in those nominees receiving fewer votes but will not count as a vote against the nominees. Broker non-votes will have no effect on this proposal.

Recommendation

THE BOARD RECOMMENDS A VOTE “FOR” EACH OF THE NOMINEES.

TABLE OF CONTENTS

PROPOSAL 2:

RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The audit committee of the Board has appointed dbbmckennon as our independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending December 31, 2024. Dbbmckennon has audited our financial statements since August 2023. Representatives of dbbmckennon are expected to be present at the Annual Meeting, will be given an opportunity to make a statement if they so desire and are expected to be available to respond to appropriate questions.

Stockholder ratification of the appointment of dbbmckennon is not required by our Bylaws or other applicable legal requirements. However, the Board is submitting the selection of dbbmckennon to our stockholders for ratification as a matter of good corporate governance. If our stockholders fail to ratify the selection, the audit committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the audit committee in its discretion may direct the appointment of a different independent registered public accounting firm at any time during the year if they determine that such a change would be in the best interests of the Company and our stockholders.

Independent Registered Public Accounting Firm Fees and Services

The following table represents aggregate fees billed to the Company for the fiscal years ended December 31, 2023 and 2022 by dbbmckennon, our independent registered public accounting firm.

	2023	2022
Audit Fees	$482,000	$411,000
Total	$482,000	$411,000

Audit Fees. This category consists of fees for professional services rendered for the audits of our financial statements which were billed during the respective year, including the audits of our annual financial statements and reviews of our interim quarterly reports, and services provided in connection with SEC filings, including consents and comfort letters.

Pre-Approval Policies and Procedures

Pursuant to its charter, our audit committee is responsible for pre-approving all audit and permissible non-audit services and related engagement fees and terms for services provided to us by our independent registered public accounting firm (or subsequently approving non-audit services in those circumstances where a subsequent approval is necessary and permissible). The audit committee’s charter gives the audit committee the power to delegate to one or more members of the audit committee the authority to pre-approve audit and permissible non-audit services. The audit committee has all of the audit and permissible non-audit services covered by the audit fees.

Required Vote

Approval of this Proposal 2 requires the affirmative vote (i.e., “FOR” votes) of the holders of a majority of the votes cast for or against at the Annual Meeting. Abstentions will have no effect on the outcome of this proposal. Brokers are entitled to vote on this proposal.

Recommendation

THE BOARD RECOMMENDS A VOTE “FOR” PROPOSAL 2.

Change in Independent Registered Public Accounting Firm

As previously disclosed, on December 8, 2022, the audit committee of the Board approved the engagement of BDO USA, LLP (“BDO”) as the Company’s independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ended December 31, 2022. BDO served as the independent registered public accounting firm of Legacy Getaround prior to the Business Combination. Accordingly, Marcum LLP (“Marcum”), InterPrivate II’s independent registered public accounting firm prior to the Business Combination, was informed on December 13, 2022, that it would be replaced by BDO as the Company’s independent registered public accounting firm, effective December 8, 2022.

TABLE OF CONTENTS

The report of Marcum on InterPrivate II’s financial statements as of December 31, 2021, and the related statements of operations, changes in stockholders’ deficit and cash flows for the year then ended, did not contain an adverse opinion or a disclaimer of opinion, nor was it qualified or modified as to uncertainty, audit scope or accounting principles, except that such report contained an explanatory paragraph which noted that there was substantial doubt as to the Company’s ability to continue as a going concern because the Company’s cash and working capital as of December 31, 2021, were not sufficient to complete its planned activities for a reasonable period of time.

During the period from September 10, 2020 (inception), through December 31, 2021, and subsequent interim periods through December 8, 2022, there were no disagreements between InterPrivate II and Marcum on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Marcum, would have caused it to make reference to the subject matter of the disagreement in connection with its report covering such period.

During the period from September 10, 2020 (inception), through December 31, 2021, and subsequent interim periods through December 8, 2022, there were no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K under the Exchange Act) other than the material weaknesses identified in InterPrivate II’s internal control over financial reporting related to (i) the classification of the private warrants as components of equity instead of as derivative liabilities, as previously disclosed in InterPrivate II’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021, (ii) accounting for complex financial instruments, including the classification of Class A Stock subject to redemption, as previously disclosed in InterPrivate II’s Current Report on Form 8-K filed with the SEC on November 17, 2021, and (iii) an adjustment to reflect an accrual as of December 31, 2021, as previously disclosed in InterPrivate II’s Annual Report on Form 10-K for the year ended December 31, 2021. The material weakness related to accounting for complex financial instruments resulted in the restatement of InterPrivate II’s interim financial statements for the quarterly periods ended March 31, 2021, and June 30, 2021, in InterPrivate II’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021.

The Company previously provided Marcum with a copy of the disclosures regarding the dismissal reproduced in this Proxy Statement and received a letter from Marcum, dated December 14, 2022, and addressed to the SEC, stating that they agree with the above statements. This letter was filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on December 14, 2022.

During the period from September 10, 2020 (inception), through December 8, 2022, the date the audit committee of the Board approved the engagement of BDO as the Company’s independent registered public accounting firm, neither InterPrivate II nor anyone on InterPrivate II’s behalf consulted with BDO regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and no written report or oral advice was provided to the Company by BDO that BDO concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement, as that term is described in Item 304(a)(1)(iv) of Regulation S-K under the Exchange Act, or a reportable event, as that term is defined in Item 304(a)(1)(v) of Regulation S-K under the Exchange Act.

In addition, as previously disclosed, effective as of August 10, 2023, BDO was replaced as the Company’s independent registered public accounting firm by dbbmckennon. The dismissal of BDO and appointment of dbbmckennon was made following a selection process conducted by the audit committee to determine a replacement for BDO as the Company’s independent registered public accounting firm. As a result of this process, on August 8, 2023, the audit committee approved the appointment of dbbmckennon as the Company’s independent registered public accounting firm, effective upon the dismissal of BDO, to audit our consolidated financial statements for the fiscal year ended December 31, 2022, and dismissed BDO as the Company’s independent registered public accounting firm as of August 10, 2023.

At the time of their dismissal, BDO had not completed the audit of the Company’s consolidated financial statements for the fiscal year ended December 31, 2022. BDO had not previously audited the financial statements of the Company for any prior period. The report of BDO on the consolidated financial statements of Legacy Getaround, the Company’s accounting predecessor, for the fiscal year ended December 31, 2021, did not contain an adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles, except that such report contained an explanatory paragraph which noted that there was substantial doubt as to the ability of Legacy Getaround to continue as a going concern because Legacy Getaround had suffered

TABLE OF CONTENTS

recurring losses from operations and had a net capital deficiency. In connection with the audit of Legacy Getaround’s consolidated financial statements for the fiscal year ended December 31, 2021, and the review of Legacy Getaround’s subsequent interim periods for the six months ended June 30, 2022, and the nine months ended September 30, 2022, respectively, there were no disagreements with BDO on any matters of accounting principles or practices, financial statement disclosure or auditing scope and procedures which, if not resolved to the satisfaction of BDO, would have caused BDO to make reference to the matter in their report. There were no reportable events (as that term is described in Item 304(a)(1)(v) of Regulation S-K) during the fiscal year ended December 31, 2021, or through BDO’s dismissal on August 10, 2023, other than the material weaknesses identified in Legacy Getaround’s internal control over financial reporting. The material weaknesses relate to the lack of proper segregation of duties relating to access controls and risk assessment process and lack of documentation for management review controls, as previously disclosed in the Company’s Current Report on Form 8-K filed with the SEC on December 14, 2022. From BDO’s engagement by the Company on December 8, 2022, through the date of their dismissal effective August 10, 2023, there has not been any matter that was the subject of a disagreement (as described in Item 304(a)(1)(iv) of Regulation S-K and the related instructions).

The Company previously provided BDO with a copy of the disclosures regarding the dismissal reproduced in this Proxy Statement and received a letter from BDO, dated August 11, 2023, and addressed to the SEC, stating that they agree with the above statements. This letter was filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on August 11, 2023.

During the Company’s fiscal year ended December 31, 2022, and the subsequent interim period through August 8, 2023, neither the Company nor anyone acting on its behalf consulted with dbbmckennon with respect to the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that would have been rendered on the Company’s consolidated financial statements, and neither a written report was provided nor oral advice was provided to the Company that dbbmckennon concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or any matter that was either the subject of a disagreement, as that term is described in Item 304(a)(1)(iv) of Regulation S-K, or a reportable event, as that term is defined in Item 304(a)(1)(v) of Regulation S-K.

TABLE OF CONTENTS

PROPOSAL 3:

APPROVAL OF THE REVERSE STOCK SPLIT PROPOSAL

The Board has approved, subject to stockholder approval, and is recommending to our stockholders for approval, an amendment to our Certificate of Incorporation (the “Reverse Stock Split Amendment”) to effect a reverse stock split at a ratio of not less than 1-for-10 and not greater than 1-for-50 (the “Reverse Stock Split”), with the exact ratio and effective time of the Reverse Stock Split to be determined by the Board at any time on or before December 31, 2024 (such proposal, the “Reverse Stock Split Proposal”). The full text of the proposed Reverse Stock Split Amendment is set forth in Annex A to this Proxy Statement.

If stockholders approve the Reverse Stock Split Proposal, the Board will cause the Reverse Stock Split Amendment to be filed with the Delaware Secretary of State and effect the Reverse Stock Split only if the Board determines that the Reverse Stock Split would be in the best interests of Getaround and its stockholders. The Reverse Stock Split could become effective as soon as the business day immediately following the Annual Meeting. The Board also may determine in its discretion not to effect the Reverse Stock Split and not to file the Reverse Stock Split Amendment. No further action on the part of stockholders will be required to either implement or abandon the Reverse Stock Split.

As of June 27, 2024, a total of 96,737,557 shares of common stock were issued and outstanding and no shares were held in treasury. Based on such number of shares of common stock issued and outstanding, immediately following the effectiveness of the Reverse Stock Split (and without giving any effect to the payment of cash in lieu of fractional shares), we will have, depending on the reverse stock split ratio selected by the Board, issued and outstanding shares of common stock as illustrated in the table below under the heading “—Effects of the Reverse Stock Split—Effect on Shares of Common Stock.”

The Reverse Stock Split Amendment will not result in a reduction of the total number of shares of common stock that Getaround is authorized to issue by a corresponding ratio, and, as a result, the number of authorized shares of common stock available for issuance will increase. See “—Effects of the Reverse Stock Split—Effect on Shares of Common Stock” for the number of shares of common stock authorized but not outstanding or reserved that will remain available for issuance immediately following the effectiveness of the Reverse Stock Split.

All holders of our common stock will be affected proportionately by the Reverse Stock Split. No fractional shares of common stock will be issued as a result of the Reverse Stock Split. Instead, any stockholder who would have been entitled to receive a fractional share as a result of the Reverse Stock Split will receive cash payments in lieu of such fractional shares. Each common stockholder will hold the same percentage of the outstanding common stock immediately following the Reverse Stock Split as that stockholder held immediately prior to the Reverse Stock Split, except to the extent that the Reverse Stock Split results in stockholders receiving cash in lieu of fractional shares. The par value of our common stock will continue to be $0.0001 per share (see “—Effects of the Reverse Stock Split—Reduction in Stated Capital”).

Reasons for the Reverse Stock Split

Reverse Stock Split

The Board has determined that it is in the best interests of Getaround and our stockholders to consider a possible combination of our shares of common stock within a range of 1-for-10 to 1-for-50, as determined by the Board at a later date, in order to reduce the number of shares of common stock outstanding. The Board may authorize the Reverse Stock Split of our common stock with the primary intent of increasing the per share trading price of our common stock in order to meet NYSE’s price criteria for continued listing on that exchange. Our common stock is publicly traded and listed on NYSE under the symbol “GETR.” Accordingly, for these and other reasons discussed below, we believe that effecting the Reverse Stock Split is in the best interests of Getaround and our stockholders.

On January 30, 2023, we received a written notice from NYSE that, because the average closing price for our common stock had fallen below $1.00 per share for 30 consecutive trading days, we no longer complied with the minimum share price criteria of Section 802.01C of the NYSE Listed Company Manual for continued listing on the NYSE. Under NYSE rules, we could regain compliance at any time within the six-month period following receipt of the NYSE notice if on the last trading day of any calendar month during the cure period we had a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. In the notice, NYSE stated that in the event a $1.00 share price and a $1.00 average share price over the preceding 30 trading days are not attained at the expiration of the six-month cure period, NYSE

TABLE OF CONTENTS

may commence suspension and delisting procedures. NYSE reserves the right to reevaluate its continued listing determinations relating to companies who are notified of non-compliance like Getaround with respect to NYSE’s qualitative listing standards, including if our common stock trades at sustained levels that are considered to be abnormally low. Separately, if a company like Getaround determines that in order to cure the price condition it is necessary to take an action that requires shareholder approval, that company must inform NYSE and obtain stockholder approval by no later than its next annual meeting, and must implement the action promptly thereafter. In such scenario, the price condition will be deemed cured if the price promptly exceeds $1.00 per share, and the price remains above the level for at least the following 30 trading days. We promptly responded to NYSE with respect to our intent to cure the deficiency by considering available alternatives to regain compliance.

The Board has considered the potential harm to Getaround and our stockholders should NYSE delist our common stock. Delisting may adversely affect our ability to raise additional financing through the public or private sale of equity securities, may significantly affect the ability of investors to trade our securities and may negatively affect the value and liquidity of our common stock. Delisting would also constitute a “Fundamental Change” under the terms of the indenture governing the Convertible Notes, whereupon the noteholders may require us to repurchase for cash all or part of their Convertible Notes at a purchase price equal to the principal amount of the Convertible Notes to be repurchased, plus a make-whole premium and accrued and unpaid interest to, but excluding, the repurchase date. In addition, the occurrence of such “Fundamental Change” under the terms of the indenture governing the Convertible Notes would constitute an “Event of Default” under the terms of the Mudrick Super Priority Note. Delisting also could have other negative results, including the potential loss of employee confidence, the loss of institutional investors or interest in business development opportunities.

The Board believes that the proposed Reverse Stock Split is a potentially effective means for us to maintain compliance with the NYSE minimum share price criteria and to avoid, or at least mitigate, the likely adverse consequences of our common stock being delisted from NYSE by producing the immediate effect of increasing the per share trading price of our common stock. Although we believe that implementing the Reverse Stock Split is likely to lead to compliance with the NYSE minimum share price criteria, there can be no assurance that the per share trading price after implementation of the Reverse Stock Split will succeed in restoring or maintaining such compliance.

We believe that maintaining listing on NYSE will provide us with a market for our common stock that is more accessible than if our common stock were traded on the over-the-counter markets. Such alternative markets are generally considered to be less efficient than, and not as broad as, NYSE. Further, a NYSE listing may enhance our access to capital, increase our flexibility in responding to anticipated capital requirements and facilitate the use of our common stock in any strategic or financing transactions that we may undertake. We believe that prospective investors will view an investment in us more favorably if our common stock continues to be listed on NYSE as compared with the over-the-counter markets.

In addition to the foregoing, we also believe that the Reverse Stock Split may make our common stock more attractive to a broader range of institutional and other investors, as we have been advised that the current per share trading price of our common stock may affect its acceptability to certain institutional investors, professional investors and other members of the investing public. Many brokerage houses and institutional investors have internal policies and practices that either prohibit them from investing in low-priced stocks or tend to discourage individual brokers from recommending low-priced stocks to their customers. In addition, some of those policies and practices may function to make the processing of trades in low-priced stocks economically unattractive to brokers.

The Board also believes that the Company’s employees and directors who are compensated in the form of our equity-based securities may be less incentivized and invested in the Company if our common stock is no longer listed on NYSE. Accordingly, the Board believes that maintaining the NYSE listing for our common stock can help attract, retain, and motivate employees and members of the Board. Additionally, the Reverse Stock Split will have the effect of increasing the number of shares available for issuance under the Certificate of Incorporation such that we will have a sufficient number of shares available to be reserved for issuance under the Convertible Notes if the Convertible Note Share Issuance Proposal, the Inducement Grant Share Issuance Proposal and the Equity Incentive Plan Proposal are each approved by our stockholders at the Annual Meeting.

Reducing the number of outstanding shares of our common stock through the Reverse Stock Split is intended, absent other factors, to increase the per share trading price of our common stock. However, other factors, such as our financial results, market conditions and the market perception of our business may adversely affect the per share

TABLE OF CONTENTS

trading price of our common stock. As a result, there can be no assurance that the Reverse Stock Split, if completed, will result in the intended benefits described above, that the per share trading price of our common stock will increase following the Reverse Stock Split or that the per share trading price of our common stock will not decrease in the future.

In light of the factors mentioned above, the Board approved the proposed Reverse Stock Split Amendment to effect the Reverse Stock Split as a potential means of increasing and maintaining the per share trading price of our common stock to above $1.00 per share in compliance with the NYSE continued listing requirements.

Criteria to Be Used for Determining Whether to Implement the Reverse Stock Split

In determining whether to implement the Reverse Stock Split and which reverse stock split ratio to implement, if any, following receipt of stockholder approval of the Reverse Stock Split Proposal, the Board may consider, among other things, various factors, such as:

•	the historical trading price and trading volume of our common stock;

•	the criteria set forth in the NYSE Listed Company Manual for continued listing on NYSE;

•	the then-prevailing trading price and trading volume of our common stock and the expected effect of the Reverse Stock Split on the trading market for our common stock in the short- and long-term;

•	the amount of shares needed to be reserved for issuance if the Convertible Note Share Issuance Proposal, the Inducement Grant Share Issuance Proposal or the Equity Incentive Plan Proposal are approved by our stockholders at the Annual Meeting; and

•	prevailing general market and economic conditions.

Certain Risks and Potential Disadvantages Associated with the Reverse Stock Split

There can be no assurance that the proposed Reverse Stock Split will increase our stock price.

We expect that the Reverse Stock Split will increase the per share trading price of our common stock. However, the effect of the Reverse Stock Split on the per share trading price of our common stock cannot be predicted with any certainty, and the history of reverse stock splits for other companies is varied, particularly since some investors may view a reverse stock split negatively. It is possible that the per share trading price of our common stock after the Reverse Stock Split will not increase in the same proportion as the reduction in the number of outstanding shares of our common stock following the Reverse Stock Split, and the Reverse Stock Split may not result in a per share trading price that would attract investors who do not trade in lower priced stocks. In addition, although we believe the Reverse Stock Split may enhance the marketability of our common stock to certain potential investors, we cannot assure you that, if implemented, our common stock will be more attractive to investors. Even if we implement the Reverse Stock Split, the per share trading price of our common stock may decrease due to factors unrelated to the Reverse Stock Split, including our future performance. If the Reverse Stock Split is consummated and the per share trading price of the common stock declines, the percentage decline as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of the Reverse Stock Split.

Even if our stockholders approve the Reverse Stock Split and the Reverse Stock Split is effected, there can be no assurance that we will meet the continued listing standards of NYSE.

One of the purposes for the proposed Reverse Stock Split is to comply with the minimum share price criteria of the NYSE continued listing standards. However, there can be no assurance we will be able to maintain the listing of our common stock on the NYSE through the Reverse Stock Split alone.

As described above, on January 30, 2023, we received a written notice from NYSE that, because the average closing price for our common stock had fallen below $1.00 per share for 30 consecutive trading days, we no longer comply with the minimum share price criteria of Section 802.01C of the NYSE Listed Company Manual for continued listing on the NYSE. On March 27, 2023, we received a written notice from NYSE that we were not in compliance with Section 802.01B of the NYSE Listed Company Manual because our average global market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, our last reported stockholders’ equity was less than $50 million. Under NYSE procedures, we had 45 days from our receipt of the March 2023 notice to submit a plan to the NYSE demonstrating how we intend to regain compliance with the

TABLE OF CONTENTS

global market capitalization continued listing standard within 18 months, which compliance plan the NYSE accepted on June 27, 2023. On April 18, 2023, we received a written notice from NYSE that we were not in compliance with Section 802.01E of the NYSE Listed Company Manual, which requires timely filing of all required periodic reports with the SEC, because of our failure to timely file our annual report on Form 10-K for the fiscal year ended December 31, 2022. We subsequently regained compliance with Section 802.01E of the NYSE Listed Company Manual by filing our delinquent annual report on Form 10-K and delinquent quarterly reports on Form 10-Q in November and December 2023, respectively. On January 5, 2024, we received a written notice from NYSE that we were not in compliance with Sections 302 and 303A of the NYSE Listed Company Manual because of our failure to hold an annual meeting in respect of our fiscal year ended December 31, 2022, by December 31, 2023. We expect to regain compliance with Section 802.01E of the NYSE Listed Company Manual following the Annual Meeting to which this Proxy Statement relates, which meeting is being held in respect of our fiscal years ended December 31, 2022 and 2023. On February 27, 2024, we received a written notice from NYSE that we were not in compliance with Sections 303A.01 and 303A.07(a) of the NYSE Listed Company Manual, which requires the Board to have a majority of independent directors and our audit committee to have a minimum of three members, respectively, following Mr. Fattouh’s resignation from the Board on January 19, 2024. We have since regained compliance with Section 303A.01 of the NYSE Listed Company Manual upon the appointment of Messrs. Patel, Salvage and Sharif to the Board effective May 6, 2024, each of whom the Board determined is “independent” as that term is defined under the NYSE listing standards, and with Section 303A.07(a) of the NYSE Listed Company Manual upon the appointment of Mr. Patel to the audit committee effective June 5, 2024. See “Board of Directors and Corporate Governance.” If we fail to regain compliance with Sections 302, 303A, 802.01B, or 802.01C of the NYSE Listed Company Manual during the respective cure periods or if we fail to meet material aspects of the compliance plan, the NYSE may commence suspension and delisting procedures.

If the NYSE delists our common stock from trading on its exchange for failure to meet the continued listing standards, we and our securityholders could face significant material adverse consequences including:

•	a limited availability of market quotations for our securities;

•	reduced liquidity for our securities;

•	a determination that our common stock is a “penny stock,” which will require brokers trading in our common stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our common stock;

•	a limited amount of analyst coverage; and

•	a decreased ability to issue additional securities or obtain additional financing in the future.

In addition, delisting would constitute a “Fundamental Change” under the indenture governing the Convertible Notes, which could result in our being required to repurchase the Convertible Notes, and constitute an “Event of Default” under the Mudrick Super Priority Note.

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” If our common stock was not listed on NYSE, such securities would not qualify as covered securities and we would be subject to regulation in each state in which we offer our securities because states are not preempted from regulating the sale of securities that are not covered securities.

The proposed Reverse Stock Split may decrease the liquidity of our common stock and result in higher transaction costs.

The liquidity of our common stock may be negatively affected by the Reverse Stock Split, given the reduced number of shares that would be outstanding after the Reverse Stock Split, particularly if the per share trading price does not increase as a result of the Reverse Stock Split. In addition, if the Reverse Stock Split is implemented, it is expected to increase the number of our stockholders who own “odd lots” of fewer than 100 shares of common stock. These odd lots may be more difficult to sell, or require greater transaction costs per share to sell, than shares in “round lots” of even multiples of 100 shares. Accordingly, the Reverse Stock Split may not achieve the desired results of increasing marketability of our common stock as described above.

TABLE OF CONTENTS

The proposed Reverse Stock Split could make a takeover proposal more difficult.

The Reverse Stock Split would result in an increased proportion of unissued authorized shares to issued shares, which could have possible anti-takeover effects and could be used by us to oppose a hostile takeover attempt or to delay or prevent changes in our control or management (for example, by permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition of the Board or contemplating a tender offer or other transaction for the combination of us with another company). These authorized but unissued shares could (within the limits imposed by applicable law) be issued in one or more transactions that could make a change of control of Getaround more difficult, and therefore more unlikely, or used to resist or frustrate a third-party transaction that is favored by a majority of the independent stockholders. For example, without further stockholder approval, the Board could (within the limits imposed by applicable law) strategically sell shares of common stock in a private transaction to purchasers who would oppose a takeover or favor our then-current Board, or the shares could be available for potential issuance pursuant to a shareholder rights plan. The additional authorized shares could be used to discourage persons from attempting to gain control of us by diluting the voting power of shares then outstanding or increasing the voting power of persons that would support the Board in a potential takeover situation, including by preventing or delaying a proposed business combination that is opposed by the Board although perceived to be desirable by some stockholders. The issuance of additional shares to certain persons allied with our management could have the effect of making it more difficult to remove our current management by diluting the stock ownership or voting rights of persons seeking to cause such removal. Despite these possible anti-takeover effects, this Reverse Stock Split Proposal has been prompted by business and financial considerations and not by the threat of any hostile takeover attempt or any effort of which we are aware to accumulate our stock or to obtain control of Getaround by means of a merger, tender offer, solicitation in opposition to management or otherwise (nor is the Board currently aware of any such attempts directed at us). Nevertheless, stockholders should be aware that approval of this Reverse Stock Split Proposal could facilitate future efforts by us to deter or prevent changes in our control, including transactions in which stockholders might otherwise receive a premium for their shares over then-current market prices.

Effective Time

The effective time of the Reverse Stock Split (the “Effective Time”), if approved by stockholders and implemented by Getaround, will be the date and time set forth in the Reverse Stock Split Amendment that is filed with the Delaware Secretary of State. Such filing may take place as soon as promptly following the Annual Meeting, assuming the stockholders approve the Reverse Stock Split Amendment and, as a result, the Effective Time could occur as soon as the business day immediately following the Annual Meeting. However, the exact timing of the filing of the Reverse Stock Split Amendment will be determined by the Board based on its evaluation as to when such action will be the most advantageous to the Company and our stockholders.

If, at any time prior to the filing of the Reverse Stock Split Amendment with the Delaware Secretary of State, notwithstanding stockholder approval, and without further action by the stockholders, the Board, in its sole discretion, determines that it is in Getaround’s best interests and the best interests of our stockholders to delay the filing of the Reverse Stock Split Amendment or to abandon the Reverse Stock Split, the Reverse Stock Split may be delayed or abandoned.

Fractional Shares

Stockholders will not receive fractional shares of common stock in connection with the Reverse Stock Split. Instead, the transfer agent will aggregate all fractional shares and sell them as soon as practicable after the Effective Time at the then-prevailing prices on the open market, on behalf of those stockholders who would otherwise be entitled to receive a fractional share as a result of the Reverse Stock Split. We expect that the transfer agent will conduct the sale in an orderly fashion at a reasonable pace and that it may take several days to sell all of the aggregated fractional shares of our common stock. After the transfer agent’s completion of such sale, stockholders who would have been entitled to a fractional share will instead receive a cash payment from the transfer agent in an amount equal to their respective pro rata shares of the total proceeds of that sale, net of any brokerage costs incurred by the transfer agent to sell such stock.

Stockholders will not be entitled to receive interest for the period of time between the Effective Time and the date payment is made for their fractional share interest. You should also be aware that, under the escheat laws of certain jurisdictions, sums due for fractional interests that are not timely claimed after the funds are made available may be required to be paid to the designated agent for each such jurisdiction. Thereafter, stockholders otherwise entitled to receive such funds may have to obtain the funds directly from the state to which they were paid.

TABLE OF CONTENTS

If you believe that you may not hold sufficient shares of our common stock at the Effective Time to receive at least one share in the Reverse Stock Split and you want to continue to hold our common stock after the Reverse Stock Split, you may do so by either:

•	purchasing a sufficient number of shares of our common stock; or

•	if you have shares of our common stock in more than one account, consolidating your accounts;

in each case, so that you hold a number of shares of our common stock in your account prior to the Reverse Stock Split that would entitle you to receive at least one share of common stock in the Reverse Stock Split. Shares of our common stock held in registered form and shares of our common stock held in “street name” (that is, through a broker, bank or other holder of record) for the same stockholder will be considered held in separate accounts and will not be aggregated when effecting the Reverse Stock Split.

Effects of the Reverse Stock Split

General

After the Effective Time of the Reverse Stock Split, if implemented by the Board, each stockholder will own a reduced number of shares of our common stock. The principal effect of the Reverse Stock Split will be to proportionately decrease the number of outstanding shares of our common stock based on the reverse stock split ratio selected by the Board.

Voting rights and other rights of the holders of our common stock will not be affected by the Reverse Stock Split, other than as a result of the treatment of fractional shares as described above. For example, a holder of 2% of the voting power of the outstanding shares of our common stock immediately prior to the effectiveness of the Reverse Stock Split will generally continue to hold 2% (assuming there is no impact as a result of the payment of cash in lieu of issuing fractional shares) of the voting power of the outstanding shares of our common stock after the Reverse Stock Split. The number of stockholders of record will not be affected by the Reverse Stock Split (except to the extent any are cashed out as a result of holding fractional shares). If approved and implemented, the Reverse Stock Split may result in some stockholders owning “odd lots” of less than 100 shares of our common stock. These odd lots may be more difficult to sell, or require greater transaction costs per share to sell, than shares in “round lots” of even multiples of 100 shares. The Board believes, however, that these potential effects are outweighed by the benefits of the Reverse Stock Split.

Because the proposed Reverse Stock Split Amendment does not result in a reduction in the total number of shares of common stock that we are authorized to issue, the implementation of the Reverse Stock Split will have the effect of increasing the number of available authorized shares of common stock. The resulting increase in such availability in the authorized number of shares of common stock could have a number of effects on our stockholders depending upon the exact nature and circumstances of any actual issuances of authorized but unissued shares. Because holders of our common stock have no preemptive rights to purchase or subscribe for any of our unissued common stock, the issuance of additional shares of authorized common stock that will become newly available as a result of the implementation of the Reverse Stock Split will reduce the current stockholders’ percentage ownership interest in the total outstanding shares of our common stock.

Effect on Shares of Common Stock

The following table contains approximate information relating to our capital structure based on reverse stock split ratios within the proposed range and assuming that the Reverse Stock Split Proposal is approved and the Reverse Stock Split is implemented, in each case based on share information as of June 27, 2024. The information below gives effect to the conversion rate adjustment to the Convertible Notes discussed below under “Proposal 4 – Approval of the Convertible Note Share Issuance Proposal,” but does not give effect to any other changes to our capital structure, including any issuances of securities after June 27, 2024.

	No Split	1-for-10	1-for-30	1-for-50
Number of authorized shares	1,000,000,000	1,000,000,000	1,000,000,000	1,000,000,000
Number of outstanding shares	96,737,557	9,673,755	3,224,585	1,934,751
Number of shares underlying outstanding Convertible Notes⁽¹⁾	810,448,848	81,044,878	27,014,959	16,208,975

TABLE OF CONTENTS

	No Split	1-for-10	1-for-30	1-for-50
Number of shares underlying outstanding warrants	16,791,642	1,679,164	559,721	335,832
Number of shares underlying outstanding equity awards⁽²⁾	102,038,487	10,203,848	3,401,282	2,040,769
Number of shares reserved for future issuance under the Equity Plans⁽³⁾	9,960,800	996,080	332,026	199,215
Number of authorized but unissued and unreserved shares⁽⁴⁾	(35,977,334)	896,402,275	965,467,427	979,280,458

(1)

Consists of shares reserved for issuance upon conversion of the Convertible Notes at an as-adjusted conversion rate of 4,000 shares per $1,000 principal amount on a pre-split basis, based on $202,612,212 aggregate principal amount of Convertible Notes (including PIK Notes) outstanding as of June 27, 2024.

(2)	Consists of shares reserved for issuance pursuant to stock options and restricted stock units outstanding as of June 27, 2024, including the Inducement Grants discussed below under “Proposal 5 – Approval of the Inducement Grant Share Issuance Proposal.”

(3)

Consists of shares reserved for future issuance under the Equity Plans as of June 27, 2024, including an assumed 4,000,000 additional shares to be reserved under the 2022 Equity Incentive Plan following the amendment and restatement thereof discussed below under “Proposal 6 – Approval of the Equity Incentive Plan Proposal,” but excluding shares issuable under outstanding equity awards.

(4)	Consists of shares authorized but unissued and unreserved for future issuance upon conversion of the Convertible Notes, exercise of the warrants or pursuant to outstanding equity awards.

After the Effective Time of the Reverse Stock Split, if implemented by the Board, our common stock will have a new Committee on Uniform Securities Identification Procedures number, or CUSIP number, used to identify our common stock.

Our common stock is currently registered under Section 12(b) of the Securities Exchange Act of 1934, or the Exchange Act, and we are subject to the periodic reporting and other requirements of the Exchange Act. The Reverse Stock Split will not affect the registration of our common stock under the Exchange Act or the listing of our common stock on the NYSE. Following the Reverse Stock Split, our common stock will continue to be listed on the NYSE under the symbol “GETR,” although it will be considered a new listing with a new CUSIP number.

No Effect on Preferred Stock Authorization

Our Certificate of Incorporation currently authorizes the issuance of 20,000,000 shares of preferred stock, $0.0001 par value per share, none of which is currently issued or outstanding. The proposed Reverse Stock Split would not increase the authorized number of shares of our preferred stock.

No Effect on Par Value

The proposed Reverse Stock Split Amendment will not affect the par value of our common stock, which will remain at $0.0001.

Reduction in Stated Capital

As a result of the Reverse Stock Split, upon the Effective Time, the stated capital on our balance sheet attributable to our common stock, which consists of the par value per share of our common stock multiplied by the aggregate number of shares of our common stock issued and outstanding, will be reduced in proportion to the size of the Reverse Stock Split, subject to a minor adjustment in respect of the treatment of fractional shares, and the additional paid-in capital account will be credited with the amount by which the stated capital is reduced. Our stockholders’ equity, in the aggregate, will remain unchanged.

Effect on Equity Plans

Under the Getaround, Inc. 2022 Equity Incentive Plan (as amended and restated, the “2022 Equity Incentive Plan”), the Getaround, Inc. Amended and Restated 2010 Stock Plan (the “2010 Stock Plan”), and the Getaround, Inc. 2022 Employee Stock Purchase Plan (the “2022 Employee Stock Purchase Plan”) (collectively, the “Equity Plans”), the compensation committee has the power to determine the appropriate adjustment to the awards granted and shares reserved for issuance under the Equity Plans in the event of a reverse stock split. Accordingly, if the Reverse Stock Split is approved and effected, prior to giving effect to the increase in shares reserved for issuance pursuant to the

TABLE OF CONTENTS

Equity Incentive Plan Proposal if approved by stockholders at the Annual Meeting, we expect that the compensation committee will proportionately adjust the number of shares available for issuance under the Equity Plans, as well as the number of shares subject to any outstanding award under the Equity Plans, and the exercise, grant price or purchase price relating to any such award or right under the Equity Plans to reflect the Reverse Stock Split. The compensation committee will also determine the treatment of fractional shares subject to stock options and other outstanding awards under the Equity Plans. In addition, pursuant to the authority provided under the Equity Plans, the compensation committee is expected to authorize the Company to effect any other changes necessary, desirable or appropriate to give effect to the Reverse Stock Split, including any applicable technical, conforming changes to the Equity Plans.

Specifically, it is expected that the number of shares subject to awards under the Equity Plans will be adjusted in each case to equal the product of the number of shares subject to the applicable award immediately prior to the Reverse Stock Split multiplied by the reverse stock split ratio (rounded down to the nearest whole share), that the exercise price of any stock option will be adjusted to equal the quotient of the number of shares subject to the applicable stock option immediately prior to the Reverse Stock Split divided by the reverse stock split ratio (rounded up to the nearest whole cent), and that the stock price goal of any performance-based restricted stock units will be adjusted in each case to equal the product of the applicable price goal in effect immediately prior to the Reverse Stock Split multiplied by the reverse stock split ratio (rounded up to the nearest whole cent).

For more information about the 2022 Equity Incentive Plan, see “Proposal 6 – Approval of the Equity Incentive Plan Proposal.”

Effect on Warrants

If the Reverse Stock Split is approved and effected, our outstanding warrants to purchase shares of our common stock will be proportionately adjusted in accordance with the respective warrant agreements to reflect the Reverse Stock Split, including the number of shares purchasable upon exercise of such warrants and their exercise prices.

Effect on Convertible Notes

If the Reverse Stock Split is approved and effected, the conversion rate of the Convertible Notes will be proportionately adjusted in accordance with the indenture governing the Convertible Notes to reflect the Reverse Stock Split. For more information about the Convertible Notes, see “Proposal 4 – Approval of the Convertible Note Share Issuance Proposal.”

Interests of Certain Persons

When you consider the Board’s recommendation to vote in favor of this Reverse Stock Split Proposal, you should be aware that certain of our directors and executive officers and existing stockholders have an interest in this Reverse Stock Split Proposal as a result of their ownership of shares of our common stock, as set forth in the section entitled “Security Ownership of Certain Beneficial Owners and Management” in this Proxy Statement. However, we do not believe that our directors and executive officers have interests in this Reverse Stock Split Proposal that are different from or greater than those of any of our other stockholders.

Shares Held in Book-Entry and Through a Broker, Bank, or Other Holder of Record

If you hold registered shares of our common stock in a book-entry form, you do not need to take any action to receive your post-Reverse Stock Split shares of our common stock in registered book-entry form or your cash payment in lieu of fractional shares, if applicable. If you are entitled to post-Reverse Stock Split shares of our common stock, a transaction statement will automatically be sent to your address of record as soon as practicable after the Effective Time indicating the number of shares of our common stock you hold. In addition, if you are entitled to a payment of cash in lieu of fractional shares, a check will be mailed to you at your registered address as soon as practicable after the Effective Time. By signing and cashing this check, you will warrant that you owned the shares of our common stock for which you received a cash payment.

At the Effective Time, we intend to treat stockholders holding shares of our common stock in “street name” (that is, through a broker, bank or other holder of record) in the same manner as registered stockholders whose shares of our common stock are registered in their names. Brokers, banks or other holders of record will be instructed to effect the Reverse Stock Split for their beneficial holders holding shares of our common stock in “street name”; however,

TABLE OF CONTENTS

these brokers, banks or other holders of record may apply their own specific procedures for processing the Reverse Stock Split. If you hold your shares of our common stock with a broker, bank or other holder of record, and you have any questions in this regard, we encourage you to contact your holder of record.

U.S. Federal Income Tax Considerations

The following is a summary of certain U.S. federal income tax consequences of the Reverse Stock Split that are generally expected to be applicable to stockholders that hold their shares of common stock as capital assets within the meaning of Section 1221 of the U.S. Internal Revenue Code of 1986, as amended, or the Code (generally property held for investment). This summary is based upon the provisions of the Code, Treasury regulations promulgated thereunder, administrative rulings and judicial decisions, all as in effect as of the date hereof, and all of which are subject to change and differing interpretations, possibly with retroactive effect. Changes in these authorities or their interpretation may result in the U.S. federal income tax consequences of the Reverse Stock Split differing substantially from the consequences summarized below. This summary, except for the discussion under “—Information Reporting and Backup Withholding” below, is limited to stockholders who are U.S. Holders (as defined below).

This summary is for general information purposes only and does not address all aspects of U.S. federal income taxation that may be relevant to U.S. Holders in light of their particular circumstances. For example, and without limitation, this summary does not address the potential application of any alternative minimum tax consequences, nor does it address any consequences arising under special U.S. tax rules applicable to individuals whose stock may meet the requirements for being “qualified small business stock.” The summary also does not apply to any U.S. Holders that may be subject to special tax rules, including, without limitation: (i) banks, insurance companies, or other financial institutions; (ii) tax-exempt organizations; (iii) dealers in securities or commodities; (iv) regulated investment companies or real estate investment trusts; (v) entities which are classified for U.S. tax purposes as partnerships (and their partners or members); (vi) traders in securities that elect to use the mark-to-market method of accounting; (vii) persons whose “functional currency” is not the U.S. dollar; (viii) persons holding our common stock in a hedging transaction, “straddle,” “conversion transaction” or other risk reduction transaction; (ix) persons who acquired our common stock in connection with employment or the performance of services; (xi) retirement plans; (xii) persons who are not treated as U.S. Holders for U.S. federal income tax purposes; or (xiii) certain former citizens or long-term residents of the United States.

In addition, this summary does not address: (a) the tax consequences of transactions effectuated before, after or at the same time as the Reverse Stock Split, whether or not they are in connection with the Reverse Stock Split; (b) any U.S. federal non-income tax consequences of the Reverse Stock Split, including estate, gift or other tax consequences; (c) any state, local or non-U.S. tax consequences of the Reverse Stock Split; (d) the Medicare contribution tax on net investment income; or (e) tax consequences to holders of options or similar rights to acquire our common stock. No ruling from the Internal Revenue Service (“IRS”), or opinion of counsel, has been or will be requested in connection with the Reverse Stock Split. Stockholders should be aware that the IRS could adopt a position which could be sustained by a court contrary to that set forth in this discussion. Accordingly, each stockholder should consult with such stockholder’s own tax advisor with respect to all of the potential tax consequences to such stockholder of the Reverse Stock Split.

For purposes of this discussion, a “U.S. Holder” means a beneficial owner of shares of our common stock that is any of the following:

•	an individual who is a citizen or resident of the United States or someone treated as a U.S. citizen or resident for U.S. federal income tax purposes;

•	a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the District of Columbia;

•	an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or

•

a trust if (i) a U.S. court can exercise primary supervision over the trust’s administration and one or more “United States persons” (within the meaning of Section 7701(a)(30) of the Code) are authorized or have the authority to control all substantial decisions of the trust or (ii) it has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a United States person for U.S. federal income tax purposes.

TABLE OF CONTENTS

If an entity which is classified as a partnership for U.S. federal income tax purposes holds shares of our common stock, the tax treatment of a partner in the partnership generally will depend upon the status of the partner and the activities of the partnership. Partnerships holding our common stock and the partners therein should consult their tax advisors regarding the tax consequences to them of the Reverse Stock Split.

EACH STOCKHOLDER SHOULD CONSULT ITS TAX ADVISORS WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT TO SUCH STOCKHOLDER.

Taxation of U.S. Holders

The Reverse Stock Split should constitute a “recapitalization” for U.S. federal income tax purposes. As a recapitalization, except as described below with respect to cash received in lieu of fractional shares, a U.S. Holder should not recognize gain or loss as a result of the Reverse Stock Split. A U.S. Holder’s aggregate tax basis in the shares of the common stock received pursuant to the Reverse Stock Split should equal the U.S. Holder’s aggregate tax basis in the shares of the common stock surrendered, and such U.S. Holder’s holding period in the shares of the common stock received should include the holding period of the shares of the common stock surrendered. Treasury regulations promulgated under the Code provide detailed rules for allocating the tax basis and holding period of shares of common stock surrendered pursuant to the Reverse Stock Split to shares of common stock received pursuant to the Reverse Stock Split. U.S. Holders holding shares of common stock that were acquired on different dates and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding period of such shares.

A U.S. Holder who receives cash in lieu of a fractional share of common stock pursuant to the Reverse Stock Split as a result of sales for cash on the open market generally should recognize capital gain or loss in an amount equal to the difference, if any, between the amount of cash received and the portion of the U.S. Holder’s tax basis in the shares of common stock surrendered that is allocated to such fractional share of common stock. Such capital gain or loss generally should be long-term capital gain or loss if the U.S. Holder’s holding period for the common stock surrendered in the Reverse Stock Split exceeds one year at the time of the Reverse Stock Split. Long-term capital gains of non-corporate U.S. Holders are generally subject to preferential tax rates. There are limitations on the deductibility of capital losses under the Code.

Information Reporting and Backup Withholding

Stockholders may be subject to information reporting with respect to any cash received in exchange for a fractional share interest in a new share in the Reverse Stock Split. Stockholders who are subject to information reporting and who do not provide a correct taxpayer identification number and other required information (such as by submitting a properly completed IRS Form W-9) may also be subject to backup withholding, at the applicable rate. Any amount withheld under such rules is not an additional tax and may be refunded or credited against the stockholder’s U.S. federal income tax liability, provided that the required information is properly furnished in a timely manner to the Internal Revenue Service.

No Dissenters’ or Appraisal Rights

Under applicable Delaware law, our stockholders are not entitled to dissenters’ or appraisal rights with respect to the proposed amendment to the Certificate of Incorporation to effect the Reverse Stock Split. We will not independently provide our stockholders with any such right.

Required Vote

Approval of this Proposal 3 requires the affirmative vote (i.e., “FOR” votes) of the holders of a majority of the votes cast for or against at the Annual Meeting. Abstentions will have no effect on the outcome of this proposal. Because brokers have discretionary authority to vote on this proposal, we do not expect any broker non-votes in connection with this proposal.

Recommendation

THE BOARD RECOMMENDS A VOTE “FOR” PROPOSAL 3.

TABLE OF CONTENTS

PROPOSAL 4:

APPROVAL OF THE CONVERTIBLE NOTE SHARE ISSUANCE PROPOSAL

The Board is asking stockholders to consider and vote upon a proposal to approve, for purposes of complying with Section 312.03 of the NYSE Listed Company Manual, the potential issuance of the shares of common stock issuable upon the conversion of the Convertible Notes after giving effect to the conversion rate adjustment discussed below (such proposal, the “Convertible Note Share Issuance Proposal”).

The Convertible Notes

On December 8, 2022, in connection with the consummation of the Business Combination, we issued $175.0 million aggregate principal amount of senior secured convertible notes (the “Convertible Notes”) pursuant to a convertible note subscription agreement, dated May 11, 2022, as amended December 8, 2022, by and among InterPrivate II and Mudrick Capital Management L.P. (“Mudrick”), on behalf of certain funds, investors, entities or accounts that are managed, sponsored or advised by Mudrick or its affiliates (collectively, “noteholders”). The Convertible Notes accrue interest payable semi-annually in arrears on June 15 and December 15 of each year, at a rate of 8.00% per annum (if paid in cash) or 9.50% per annum (if paid in-kind) (“PIK Interest”). Convertible Notes issuable in respect of any such payment of PIK Interest are hereinafter referred to as “PIK Notes.” Upon the occurrence, and during the continuation, of an event of default, an additional 2.00% will be added to the stated interest rate. The Convertible Notes will mature on December 8, 2027, unless earlier converted, redeemed or repurchased.

The Convertible Notes are convertible at the option of the noteholders at any time until the close of business on the second scheduled trading day immediately before the maturity date. Conversions of the Convertible Notes will be settled in shares of common stock. The initial conversion rate of the Convertible Notes was 86.96 shares of common stock per $1,000 principal amount of Convertible Notes, which is equivalent to an initial conversion price of approximately $11.50 per share. The initial conversion price was subject to a downward adjustment to 115% of the average daily volume-weighted average trading price (“VWAP”) of common stock for the 90 trading days after the closing of the Business Combination, subject to a minimum conversion price of $9.21 per share. Pursuant to the terms of the indenture governing the Convertible Notes, effective as of April 21, 2023, the conversion price for the Convertible Notes was automatically adjusted downward to the minimum conversion price of $9.21 per share, which is equivalent to a conversion rate of approximately 108.58 shares of common stock per $1,000 principal amount of Convertible Notes. The conversion price is subject to further adjustments as provided in the indenture, including downward adjustments in connection with certain issuances of our capital stock or indebtedness convertible into capital stock following the issue date of the Convertible Notes with a weighted-average issue price (or conversion price) per share less than the then-effective conversion price, subject to a minimum conversion price of $6.00 per share.

On September 8, 2023, we entered into certain agreements related to the consolidation and refinancing of certain bridge indebtedness and the borrowing of additional funds pursuant to a subscription agreement, dated September 8, 2023 (the “Subscription Agreement”), entered into with Mudrick, on behalf of certain funds, investors, entities or accounts that are managed, sponsored or advised by it. (For additional information about these transactions, see “Certain Relationships and Related Party Transactions – Investments by Mudrick Capital Management.”) We agreed in the Subscription Agreement to effectuate an adjustment to the conversion rate of the Convertible Notes to 4,000 shares of common stock per $1,000 principal amount of the Convertible Notes, which is equivalent to a conversion price of $0.25 per share. We also agreed in the Subscription Agreement to hold a stockholder meeting as soon as reasonably practicable to obtain stockholder approval for the conversion rate adjustment described above for purposes of complying with the NYSE Listed Company Manual. In connection with the refinancing transaction, and pursuant to the Subscription Agreement, we obtained stockholder voting and support agreements for the approval of any proposal at any stockholder meeting relating to the approval of the conversion rate adjustment for purposes of complying with the NYSE Listed Company Manual from certain stockholders beneficially owning an aggregate of approximately 43.7 million shares of our common stock, or approximately 45.1% of the outstanding shares as of the Record Date, that are entitled to vote at such stockholder meeting (see “—Interests of Certain Persons”).

We expect to effect the conversion rate adjustment by entering into a supplemental indenture to the indenture governing the Convertible Notes as soon as practicable following the receipt of stockholder approval for this Convertible Note Share Issuance Proposal.

Additional information concerning the Convertible Notes and the Subscription Agreement is contained in the Annual Report, which is incorporated by reference herein.

TABLE OF CONTENTS

Reason for Seeking Stockholder Approval

Under Section 312.03 of the NYSE Listed Company Manual, stockholder approval is required prior to the issuance of shares of common stock, or of securities convertible into or exercisable for common stock, in certain circumstances, including if the number of shares of common stock to be issued is, or will be upon issuance, equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the common stock or of securities convertible into or exercisable for common stock.

At a special meeting held on December 7, 2022, the Company’s stockholders previously approved, for purposes of complying with the applicable listing rules of NYSE, the issuance of shares of common stock upon future conversion of the Convertible Notes in accordance with their terms in effect at the time the Convertible Notes were initially issued because the maximum aggregate number of shares of common stock then-issuable upon future conversion of the Convertible Notes represented greater than 20% of the number of shares of the Company’s common stock outstanding before the Convertible Notes were issued.

After giving effect to the adjustment to the conversion rate of the Convertible Notes to 4,000 shares of common stock per $1,000 principal amount of the Convertible Notes, the additional number of shares of common stock issuable upon future conversion of the Convertible Notes will represent greater than 20% of the number of shares of common stock outstanding before such conversion rate adjustment is effected. The maximum number of additional shares of common stock issuable upon future conversion of the Convertible Notes at the as-adjusted conversion rate cannot be conclusively determined as of the date of this Proxy Statement because this number will be based on, among other things, the aggregate principal amount of Convertible Notes (including PIK Notes) outstanding at the time a noteholder elects to convert their Convertible Notes. Although such number is uncertain, based on $202,612,212 aggregate principal amount of Convertible Notes (including PIK Notes) outstanding as of June 27, 2024, the conversion rate adjustment would provide for a maximum issuance of 810,448,848 shares of common stock upon conversion at the as-adjusted conversion rate of 4,000 shares of common stock per $1,000 principal amount, as compared to a maximum issuance of 21,999,154 shares of common stock upon conversion at the current conversion rate of 108.58 shares of common stock per $1,000 principal amount, in each case without giving effect to the Reverse Stock Split proposed by the Reverse Stock Split Proposal (see “Proposal 3 – The Reverse Stock Split Proposal”). The additional shares of common stock issuable upon future conversion of the Convertible Notes at the as-adjusted conversion rate exceeds 20% of the 92,941,175 shares of common stock outstanding as of the date of the Subscription Agreement and is expected to exceed 20% of the number of shares of common stock outstanding as of the effective date of the supplemental indenture giving effect to the conversion rate adjustment.

Stockholder approval of this Convertible Note Share Issuance Proposal will constitute stockholder approval for purposes of Section 312.03 of the NYSE Listed Company Manual of the potential issuance of the additional shares of common stock issuable upon the conversion of the Convertible Notes after giving effect to the conversion rate adjustment discussed above.

In the event that this Convertible Note Share Issuance Proposal is not approved by our stockholders, we will be obligated under the Subscription Agreement to seek stockholder approval for the conversion rate adjustment again in the future. In addition, in the event this Convertible Note Share Issuance Proposal is not approved by our stockholders, the holders of the Mudrick Super Priority Note issued pursuant to the Subscription Agreement could declare a default under the note, and if the default were to remain uncured, such holders would have the right to exercise their rights as a secured creditor with respect to our assets that secure the note. Further, any such event of default under the secured promissory note would also constitute an event of default under the Convertible Notes. Any such declaration by the holders of the secured promissory note of a default, or any event of default under the Convertible Notes, could significantly harm our business and prospects and could cause the price of our common stock to decline.

Interests of Certain Persons

When you consider the Board’s recommendation to vote in favor of this Convertible Note Share Issuance Proposal, you should be aware that certain of our directors and executive officers and existing stockholders may have interests that may be different from, or in addition to, the interests of other of our stockholders.

In particular, Mudrick, on behalf of the noteholders and the holder of the Mudrick Super Priority Note, and Jason Mudrick, the Chairman of the Board, in his capacity as the sole member of certain of the general partners of the noteholders and the holder of the Mudrick Super Priority Note, have an interest in the approval of this Convertible Note Share Issuance Proposal. Mr. Mudrick was initially appointed to serve on the Board on January 19, 2024, in

TABLE OF CONTENTS

connection with the closing of the Third A&R Note pursuant to the A&R Incremental Subscription Agreement. See the section entitled “Security Ownership of Certain Beneficial Owners and Management” in this Proxy Statement for information on Mudrick’s beneficial ownership of our common stock and the section entitled “Certain Relationships and Related Party Transactions – Investments by Mudrick Capital Management” for information on the Mudrick Super Priority Note and Mudrick’s director nomination rights. The terms of the Subscription Agreement and the transactions contemplated thereby, including the conversion rate adjustment, were approved by the Board prior to Mr. Mudrick becoming a member of the Board.

In addition, pursuant to the Subscription Agreement and in connection with the refinancing transaction described above, we obtained stockholder voting and support agreements from certain stockholders beneficially owning an aggregate of approximately 43.7 million shares of our common stock, or approximately 45.1% of the outstanding shares as of the Record Date, pursuant to which each such stockholder agreed to: (i) cause all of its shares of common stock to be voted for the approval of any proposal at any meeting of the stockholders of the Company relating to the approval of the downward adjustment to the conversion price of the Convertible Notes pursuant to the Subscription Agreement and (ii) not transfer any of its shares unless the transferee thereof enters into a joinder to such stockholder voting and support agreement. The stockholder voting and support agreements, and related transfer restrictions on the covered shares of common stock, will automatically terminate upon the effectiveness of the conversion rate adjustment.

Potential Adverse Effects — Dilution

If our stockholders vote to approve this Convertible Note Share Issuance Proposal, the conversion of any of the Convertible Notes at the adjusted conversion rate into shares of common stock will have a dilutive effect on current stockholders other than the noteholders in that the percentage ownership of the Company held by such other current stockholders will decline as a result of the issuance of such common stock. Issuance of common stock upon the conversion of the Convertible Notes will also have a dilutive effect on book value per share and any future earnings per share. Dilution of equity interests could also cause prevailing market prices for our common stock to decline.

Effect of Reverse Stock Split

The information set forth in this Convertible Note Share Issuance Proposal does not reflect the potential approval of the Reverse Stock Split Proposal and consummation of a Reverse Stock Split. In the event the Reverse Stock Split becomes effective, the then-effective conversion rate of the Convertible Notes will be proportionately adjusted to reflect the Reverse Stock Split. See “Proposal 3 – Approval of the Reverse Stock Split Proposal – Effects of the Reverse Stock Split” for more information.

Required Vote

Approval of this Proposal 4 requires the affirmative vote (i.e., “FOR” votes) of the holders of a majority of the votes cast for or against at the Annual Meeting. Abstentions and broker non-votes, if any, will have no effect on the outcome of this proposal.

Recommendation

THE BOARD RECOMMENDS A VOTE “FOR” PROPOSAL 4.

TABLE OF CONTENTS

PROPOSAL 5:

APPROVAL OF THE INDUCEMENT GRANT SHARE ISSUANCE PROPOSAL

The Board is asking stockholders to consider and vote upon a proposal to approve, for purposes of complying with Section 312.03 of the NYSE Listed Company Manual, the potential issuance of the shares of common stock issuable upon the exercise of the Inducement Grants (as defined below) granted to Mr. Iniguez to incentivize him to leave his previous employment and join Getaround as our Chief Executive Officer in February 2024 (such proposal, the “Inducement Grant Share Issuance Proposal”).

The Inducement Grants

On February 28, 2024, we announced that the Board had appointed Eduardo Iniguez to the position of Chief Executive Officer, effective as of February 26, 2024. In connection with his appointment, we entered into an offer letter dated February 26, 2024, with Mr. Iniguez which provided for, among other compensation, two “inducement grants,” as such term is described in Section 303A.08 of the NYSE Listed Company Manual, offered to Mr. Iniguez to incentivize him to leave his previous employment and join Getaround as our Chief Executive Officer (each, an “Inducement Grant”). The Inducement Grants were granted on February 26, 2024, outside of the 2022 Equity Incentive Plan in the form of stock options to purchase, when vested, shares of common stock at $0.25 per share, which was the closing price of Getaround common stock on the grant date.

The following table provides information regarding the Inducement Grants:

Inducement Grants

Name and Position

Grant Date

Number of

Underlying Shares

Exercise Price

Expiration Date

Eduardo Iniguez

Chief Executive Officer

02/26/2024

11,100,000

$0.25

02/26/2034

02/26/2024

76,950,000

$0.25

02/26/2034

The first Inducement Grant is for up to 11,100,000 shares of common stock, representing approximately 10% of the Company’s then-fully diluted capitalization, which shares will vest in four annual 25% installments. The second Inducement Grant is for up to 76,950,000 shares of common stock, representing approximately 10% of the Company’s pro forma fully diluted capitalization, assuming the conversion of all or nearly all of the then-currently outstanding Convertible Notes at an as-adjusted conversion rate of 4,000 shares of common stock per $1,000 principal amount of the Convertible Notes, which is equivalent to a conversion price of $0.25 per share. (See “Proposal 4 – Approval of the Convertible Note Share Issuance Proposal.”) The shares subject to the second Inducement Grant also will vest in four annual 25% installments, provided that the vesting of such shares is contingent upon the exercise of the Convertible Notes and will be delayed, in whole or in part, if necessary, so that at no time will more than the Adjusted Number of Shares (as defined below) be vested. Under the terms of the second Inducement Grant, “Adjusted Number of Shares” means the total number of shares subject to the Inducement Grant multiplied by the quotient obtained by dividing (x) the aggregate number of shares of common stock issued upon the conversion of the Convertible Notes by (y) 769,500,000, provided that in no case will the Adjusted Number of Shares exceed the total number of shares subject to the second Inducement Grant. For illustrative purposes only, in the event that Convertible Notes representing 10% of the outstanding principal amount of the Convertible Notes are converted into shares of common stock, then only 10% of the shares subject to the second Inducement Grant will vest. The Inducement Grants each have a ten-year term, subject to earlier expiration in the event Mr. Iniguez’s service with the Company terminates, and other terms and conditions similar to the terms and conditions of stock options granted under the 2022 Equity Incentive Plan. The Inducement Grants are governed by a stock option agreement in substantially the form of the Company’s Stock Option Notice and Agreement and the terms and provisions of the 2022 Equity Incentive Plan, to the extent applicable, provided that the Inducement Grants were not granted pursuant to the 2022 Equity Incentive Plan.

Additional information relating to the Inducement Grants is contained in the Annual Report, which is incorporated by reference herein.

Reason for Seeking Stockholder Approval

TABLE OF CONTENTS

to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the common stock or of securities convertible into or exercisable for common stock.

The aggregate number of shares of common stock underlying the Inducement Grants exceeds 20% of the 93,296,015 shares of common stock outstanding as of February 26, 2024, the grant date of the Inducement Grants. However, the vesting terms of the second Inducement Grant limit the exercise and issuance of common stock underlying that Inducement Grant to a percentage of the shares actually issued upon conversion of the Convertible Notes. The maximum number of shares of common stock issuable pursuant to the second Inducement Grant further assumes that the conversion rate adjustment to the Convertible Notes described under “Proposal 4 – Approval of the Convertible Note Share Issuance Proposal” is effected prior to any conversion of the Convertible Notes. Taken together, these vesting terms will effectively limit the aggregate number of shares of common stock issuable pursuant to the Inducement Grants to less than 19.9% of the common stock outstanding as of the date the second Inducement Grant first becomes exercisable. Notwithstanding that the second Inducement Grant is subject to these vesting limitations, in order to comply with the with the NYSE Listed Company Manual, we are seeking the approval of stockholders for the potential issuance of the shares underlying the Inducement Grants.

Stockholder approval of this Inducement Grant Share Issuance Proposal will constitute stockholder approval for purposes of Section 312.03 of the NYSE Listed Company Manual of the potential issuance of the shares of common stock underlying the Inducement Grants.

In the event that this Inducement Grant Share Issuance Proposal is not approved by our stockholders, Mr. Iniguez will be unable to exercise the Inducement Grants upon their vesting to the extent that such exercise would result in the issuance, in the aggregate, of more than 19.99% of the shares of our common stock outstanding.

Interests of Certain Persons

When you consider the Board’s recommendation to vote in favor of this Inducement Grant Share Issuance Proposal, you should be aware that Mr. Iniguez will personally benefit from the adoption of this Inducement Grant Share Issuance Proposal. Nevertheless, the Board believes that approval of the Inducement Grant Share Issuance Proposal is appropriate and in the best interests of the stockholders to allow Getaround and Mr. Iniguez to meet the objectives of the Inducement Grants.

Potential Adverse Effects — Dilution

If our stockholders vote to approve this Inducement Grant Share Issuance Proposal, the exercise of the Inducement Grants into shares of common stock will have a dilutive effect on current stockholders other than Mr. Iniguez in that the percentage ownership of the Company held by such other current stockholders will decline as a result of the issuance of such common stock. Issuance of such common stock will also have a dilutive effect on book value per share and any future earnings per share. Dilution of equity interests could also cause prevailing market prices for our common stock to decline.

Effect of Reverse Stock Split

The information set forth in this Inducement Grant Share Issuance Proposal does not reflect the potential approval of the Reverse Stock Split Proposal and consummation of a Reverse Stock Split. In the event the Reverse Stock Split becomes effective, the number of underlying shares and the exercise price of the Inducement Grants will be proportionately adjusted to reflect the Reverse Stock Split. See “Proposal 3 – Approval of the Reverse Stock Split Proposal – Effects of the Reverse Stock Split” for more information.

Required Vote

Approval of this Proposal 5 requires the affirmative vote (i.e., “FOR” votes) of the holders of a majority of the votes cast for or against at the Annual Meeting. Abstentions and broker non-votes, if any, will have no effect on the outcome of this proposal.

Recommendation

THE BOARD RECOMMENDS A VOTE “FOR” PROPOSAL 5.

TABLE OF CONTENTS

PROPOSAL 6:

APPROVAL OF THE EQUITY INCENTIVE PLAN PROPOSAL

Our 2022 Equity Incentive Plan (the “2022 Plan”), was originally adopted by the Board and approved by our stockholders in 2022 in connection with the Business Combination. We are asking our stockholders to approve an amended and restated 2022 Equity Incentive Plan (the “Amended 2022 Plan”) to (1) increase the number of shares of our common stock, par value $0.0001 per share, reserved for issuance thereunder by 4,000,000 shares (prior to giving effect to the reverse stock split, if Proposal 3 is approved by stockholders), (2) amend the annual “evergreen” increase to be equal to the sum of (a) 2% of the total number of shares that are issued and outstanding on the first day of the applicable fiscal year, and (b) an amount of shares equal to 10% of the aggregate number of shares issued upon the conversion of the Convertible Notes during the prior calendar year on the first day of each fiscal year the Convertible Notes are outstanding as of January 1 of that fiscal year, returning to 5% of the outstanding shares on the first day of each year thereafter through and including 2032, provided, if less, the annual “evergreen” increase shall equal the number of shares of our common stock reserved for issuance under the Amended 2022 Plan as of the date of the Annual Meeting if this Proposal 6 is approved by stockholders, or such smaller number of shares determined by the Board, and (3) extend the term of the Amended 2022 Plan for incentive stock option purposes through June 26, 2034, and, for all other purposes eliminate the term of the Amended 2022 Plan, so that we can continue to use it to achieve our goals.

We have historically provided stock options and other types of equity awards as an incentive to our employees, consultants and non-employee directors to promote increased stockholder value. The Board and management believe that stock options and other types of equity awards are one of the primary ways to attract and retain key personnel responsible for the continued development and growth of our business, and to motivate all employees to increase stockholder value. In addition, stock options and other types of equity awards are considered a competitive necessity in the high technology sector in which we compete. Given the highly competitive labor market for employee talent, the Board and management believe that the ability to continue to grant equity awards will be critical to the future success of Getaround.

Moreover, as further described below, the Board and our compensation committee have determined that it is in the best interests of the Company and its stockholders to commence a broad-based equity grant program (the “Refresh Program”) for members of our management team, including each of our executive officers (other than our chief executive officer), in light of the precipitous decline in our stock price since completion of the Business Combination and the potential dilution contemplated by the conversion rate adjustment to the Convertible Notes discussed above under “Proposal 4 – Approval of the Convertible Note Share Issuance Proposal.” However, the Refresh Program cannot be implemented without approval of this Proposal 6 because the shares available for issuance under the 2022 Plan are insufficient to achieve the objectives of the Refresh Program. The Board and our compensation committee believe that approval of the Amended 2022 Plan will enable us to implement the Refresh Program and otherwise continue to use the 2022 Plan to achieve employee performance, recruiting, retention and incentive goals. In particular, the Board and our compensation committee believe that our employees are our most valuable assets and that awards granted under the 2022 Plan are vital to our ability to attract and retain outstanding and highly skilled individuals in the extremely competitive labor markets in which we compete. Such awards also are crucial to our ability to motivate employees to achieve our goals.

If our stockholders do not approve this Proposal 6, we will be unable to implement the Refresh Program or otherwise use equity compensation to the full extent we believe is needed to provide competitive compensation to motivate and retain our employees. If this Proposal 6 is not approved at the Annual Meeting, we could be required to increase cash compensation to attract, retain and motivate our employees, which could limit our prospects.

Material Differences from the Existing 2022 Equity Incentive Plan

The following are the material differences between the existing 2022 Plan and the Amended 2022 Plan:

•	The Amended 2022 Plan increases the number of shares of our common stock reserved for issuance thereunder by 4,000,000 shares as of the date of the Annual Meeting (prior to giving effect to the reverse stock split, if Proposal 3 is approved by stockholders),

•

The Amended 2022 Plan amends the “evergreen” annual increase on the first day of each fiscal year the Convertible Notes are outstanding as of January 1 of that fiscal year to an amount of shares equal to the sum of (a) 2% of the total number of shares that are issued and outstanding on the first day of the applicable fiscal year, and (b) an amount of shares equal to 10% of the aggregate number of shares issued upon the conversion of the Convertible Notes during the prior calendar year and provides that the “evergreen” annual increase will continue in an amount of shares equal to 5% of our outstanding share count on the first

TABLE OF CONTENTS

day of each fiscal year thereafter through and including 2032, provided, if less, the annual “evergreen” increase shall equal the number of shares of our common stock reserved for issuance under the Amended 2022 Plan as of the date of the Annual Meeting if this Proposal 6 is approved by stockholders, or such smaller number of shares determined by the Board, and

•	The Amended 2022 Plan extends the term of the Amended 2022 Plan for incentive stock option purposes through June 26, 2034 and, for all other purposes, eliminates the term of the Amended 2022 Plan.

Refresh Program

Through the end of the first half of 2024, a large number of our outstanding stock options are deeply “out of the money,” providing very limited incentive and retentive value. Our compensation committee and the Board evaluated various alternatives to provide our employees with the opportunity to hold long-term equity awards that represented meaningful value and over time had a greater potential to increase in value than their existing stock options or other equity awards. Following these evaluations, in order to support the goals of incentivizing and retaining our employees critical to execute our new business plan following our chief executive officer transition earlier in 2024, and after taking into account the decline in and persistently low trading price of our common stock since the completion of the Business Combination, our burn rate, management’s recommendations and other factors discussed above, our compensation committee authorized the Refresh Program as described in the next paragraph, provided that we obtain stockholder approval of this Proposal 6, in combination with the one-time repricing of outstanding options to purchase shares of our common stock discussed below under “Proposal 7 – Approval of the Stock Option Repricing Proposal,” which is subject to stockholder approval.

If this Proposal 6 is approved, our compensation committee plans to grant equity awards (“Initial Refresh Grants”) to members of our management team and other service providers, each representing shares that will result in the recipient holding equity awards equal to a specified equity interest in the Company (“Target Ownership Percentage”), with the aggregate amount of all such grants representing approximately 10% of the aggregate number of shares of common stock outstanding on a pro forma fully diluted basis prior to the issuance of the Inducement Grants described under “Proposal 5 - Approval of the Inducement Grant Share Issuance Proposal” and the exercise of any outstanding warrants and assuming the conversion of the Convertible Notes (the “Initial Refresh Shares”). Additionally, our compensation committee plans to direct us to enter into commitments (“Letter Commitments”) to grant equity awards to our employees and other service providers on an annual basis in the future in amounts designed to neutralize the dilutive effect on the Initial Refresh Grants of the increasing aggregate number of shares of our common stock issuable upon conversion of the Convertible Notes over time. Pursuant to the Letter Commitments, each year in January, our compensation committee will grant to recipients new equity awards (each such grant, an “Annual Refresh Grant”) for an amount of shares equal to a specified percentage of the aggregate number of shares of our common stock issuable upon the conversion of the Convertible Notes outstanding as of December 31 of the prior year, less the number of shares subject to equity awards outstanding under the 2010 Stock Plan and the Amended 2022 Plan (inclusive of any prior issued Initial or Annual Refresh Grants), so long as the Convertible Notes remain outstanding. The Initial Refresh Grants and Annual Refresh Grants will vest over four years in equal annual installments and, if applicable, have an exercise price equal to the greater of (i) $0.25 per share and (ii) the closing stock price of our common stock on the date of grant.

Summary of the Amended and Restated 2022 Equity Incentive Plan

The following is a summary of the material features of the Amended 2022 Plan. The summary is qualified in its entirety by reference to the Amended 2022 Plan set forth in Annex B of this Proxy Statement.

Types of Stock Awards

The Amended 2022 Plan permits the grant of incentive stock options, nonstatutory stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”) and stock bonus awards (all such types of awards, collectively, “stock awards”).

Share Reserve

Subject to adjustments as set forth in the Amended 2022 Plan, the maximum aggregate number of shares of our common stock that may be issued under the Amended 2022 Plan will be equal to (i) 28,875,598 (prior to adjustment for the reverse split, if Proposal 3 is approved by stockholders) shares of our common stock plus (ii) 4,000,000 shares

TABLE OF CONTENTS

(prior to giving effect to the reverse stock split, if Proposal 3 is approved by stockholders). Furthermore, subject to adjustments as set forth in the Amended 2022 Plan, in no event shall the maximum aggregate number of shares that may be issued under the Amended 2022 Plan pursuant to incentive stock options exceed the number set forth above plus, to the extent allowable under Section 422 of the Code and the regulations promulgated thereunder, any shares that become available for issuance pursuant to the Amended 2022 Plan pursuant to the provisions below.

The number of shares available for issuance under the Amended 2022 Plan will be increased on the first day of each fiscal year beginning with the 2025 fiscal year through and including the first day of the 2032 fiscal year, in each case, in an amount equal to the lesser of (a) either (i) for each fiscal year the Convertible Notes are outstanding as of January 1 of that fiscal year, the sum of (x) 2% of the total number of shares that are issued and outstanding on the first day of the applicable fiscal year, and (y) an amount of shares equal to 10% of the aggregate number of shares issued upon the conversion of the Convertible Notes during the prior calendar year or (ii) for each fiscal year in which the Convertible Notes are not outstanding on January 1 of that fiscal year, as applicable and in each case through and including 2032, 5% of the total number of shares that are issued and outstanding on the first day of the applicable fiscal year, (b) the number of shares of our common stock reserved for issuance under the Amended 2022 Plan as of the date of the Annual Meeting if this Proposal 6 is approved by stockholders, and (c) such smaller number of shares determined by the Board.

To the extent a stock award, including stock options or restricted stock granted under the 2010 Stock Plan and assumed by us in the Business Combination, expires or is forfeited or becomes unexercisable for any reason without having been exercised in full, or is surrendered pursuant to an “exchange program” (as defined in the Amended 2022 Plan), the unissued shares that were subject thereto shall, unless the Amended 2022 Plan shall have been terminated, be available under the Amended 2022 Plan for issuance pursuant to future stock awards. In addition, any shares which are retained by us upon exercise of a stock award, including stock options or restricted stock units granted under the 2010 Stock Plan and assumed by us in the Business Combination, in order to satisfy the exercise or purchase price for such stock award or any withholding taxes due with respect to such stock award shall be treated as not issued and shall be available under the Amended 2022 Plan for issuance pursuant to future stock awards. Shares issued under the Amended 2022 Plan or the 2010 Stock Plan and later forfeited to us due to the failure to vest or repurchased by us at the original purchase price paid to us for the shares (including without limitation upon forfeiture to or repurchase by us in connection with a participant ceasing to be a service provider) shall be available for future grant under the Amended 2022 Plan. To the extent a stock award under the Amended 2022 Plan is paid out in cash rather than shares, such cash payment will not result in reducing the number of shares available for issuance under the Amended 2022 Plan.

Eligibility

Employees, directors and independent contractors are all eligible to participate in the Amended 2022 Plan. As of June 27, 2024, approximately 244 employees, 13 consultants and 7 non-employee directors will be eligible to be granted stock awards under the Amended 2022 Plan.

Administration

The Amended 2022 Plan will be administered by the Board or a committee thereof, which committee will be constituted to satisfy applicable laws (for purposes of this Proposal 6, the “Plan Administrator”). To the extent desirable to qualify transactions under the Amended 2022 Plan as exempt under Rule 16b-3 of the Exchange Act, the transactions contemplated under the Amended 2022 Plan will be structured to satisfy the requirements for exemption under Rule 16b-3.

Subject to the terms of the Amended 2022 Plan, the Plan Administrator has the authority, in its discretion, to (i) determine the fair market value in accordance with the Amended 2022 Plan; (ii) select the service providers to whom stock awards may be granted; (iii) determine the number of shares to be covered by each stock award granted; (iv) approve forms of stock award agreements; (v) determine the terms and conditions, not inconsistent with the terms of the Amended 2022 Plan, of any stock award granted thereunder; (vi) institute and determine the terms and conditions of an exchange program (subject to stockholder approval); (vii) construe and interpret the terms of the Amended 2022 Plan and stock awards granted thereunder; (viii) correct any defect, supply any omission or reconcile any inconsistency in the Amended 2022 Plan, any stock award or any award agreement; (ix) prescribe, amend and rescind rules and regulations relating to the Amended 2022 Plan; (x) modify or amend each stock award (subject to compliance with applicable laws); (xi) adjust performance goals to take into account changes in applicable laws or

TABLE OF CONTENTS

in accounting or tax rules, or such other extraordinary, unforeseeable, nonrecurring or infrequently occurring events or circumstances as the Plan Administrator deems necessary or appropriate to avoid windfalls or hardships; (xii) allow participants to satisfy tax withholding obligations in such manner as prescribed in the Amended 2022 Plan; (xiii) allow a participant to defer the receipt of the payment of cash or the delivery of shares that would otherwise be due to such participant under a stock award; and (xiv) make all other determinations deemed necessary or advisable for administering the Amended 2022 Plan.

To the extent permitted by applicable law, the Plan Administrator, in its sole discretion and on such terms and conditions as it may provide, may delegate all or any part of its authority and powers under the Amended 2022 Plan to one or more of our directors or officers.

The Plan Administrator will, in its sole discretion, determine the performance goals, if any, applicable to any stock award (including any adjustment(s) thereto that will be applied in determining the achievement of such performance goals) on or prior to the “determination date” (as defined in the Amended 2022 Plan). The performance goals may differ from participant to participant and from stock award to stock award. The Plan Administrator shall determine and approve the extent to which such performance goals have been timely achieved and the extent to which the shares subject to such stock award have thereby been earned. Please refer to the discussion below under “— Performance Goals” for more information.

Stock Options

Each stock option will be designated in the stock award agreement as either an incentive stock option (which is entitled to potentially favorable tax treatment) or a nonstatutory stock option, and except as specified below, the Plan Administrator will determine the terms and conditions of each stock option. However, notwithstanding such designation, to the extent that the aggregate fair market value of the shares with respect to which incentive stock options are exercisable for the first time by the participant during any calendar year exceeds $100,000, such stock options will be treated as nonstatutory stock options. Incentive stock options may only be granted to employees. The exercise price of options granted under the Amended 2022 Plan must at least be equal to 100% of the fair market value per share of our common stock on the date of grant. The term of a stock option may not exceed ten years. Notwithstanding the foregoing, in the case of an incentive stock option granted to a participant who owns stock representing more than 10% of the total combined voting power of all classes of our (or any parent or subsidiary of ours) outstanding stock, the per share exercise price will be no less than 110% of the fair market value per share on the date of grant and the term of the incentive stock option may not exceed 5 years from the date of grant. At the time a stock option is granted, the Plan Administrator will fix the period within which the stock option may vest and/or be exercised and will determine any conditions that must be satisfied before the stock option may vest and/or be exercised, which may include completion of a specified period of service with us or one of our affiliates and/or based on the achievement of performance goals during a performance period as set out in advance in the participant’s award agreement. Please refer to the discussion below under “—Performance Goals” for information regarding stock options subject to vesting based on achievement of performance goals. The Plan Administrator will also determine the acceptable form of consideration for exercising a stock option, including the method of payment.

In the absence of a specified time in the stock option agreement, the stock option will remain exercisable for 12 months following a termination for death or disability, and 3 months following a termination for any other reason other than “Cause” (as defined in the Amended 2022 Plan), but in no event later than the expiration of the term of such stock option. If a participant ceases to be a service provider for Cause, the participant may exercise his or her stock option within such period of time as is specified in the stock award agreement or, if there is no specified time in the stock option agreement, any outstanding stock option (including any vested portion thereof) held by a participant shall immediately terminate in its entirety upon the participant being first notified of his or her termination for Cause.

Stock Appreciation Rights (SARs)

The Plan Administrator will determine the terms and conditions of each SAR, provided that the exercise price for each SAR will be no less than 100% of the fair market value of the underlying shares of our common stock on the date of grant. A SAR will vest and/or become exercisable at such time, and upon such terms, as are determined by the Plan Administrator, which may include completion of a specified period of service with us or one of our affiliates and/or based on the achievement of performance goals during a performance period as set out in advance in the participant’s award agreement. Please refer to the discussion below under “—Performance Goals” for

TABLE OF CONTENTS

information regarding SARs subject to vesting based on achievement of performance goals. Upon exercise of a SAR, a participant will receive payment from us in an amount determined by multiplying the difference between the fair market value of a share on the date of exercise over the exercise price by the number of shares with respect to which the SAR is exercised. SARs may be paid in cash or shares of our common stock, as determined by the Plan Administrator. SARs are exercisable at the times and on the terms established by the Plan Administrator.

Restricted Stock and RSUs

Restricted stock awards are grants of shares of our common stock that are subject to various restrictions, including restrictions on transferability and forfeiture provisions. Shares of restricted stock will vest and the restrictions on such shares will lapse in accordance with terms and conditions established by the Plan Administrator. Each RSU is a bookkeeping entry representing an amount equal to the fair market value of one share of our common stock. RSUs will vest at such time, and upon such terms, as are determined by the Plan Administrator, which may include upon the completion of a specified period of service with us or one of our affiliates and/or based on the achievement of performance goals during a performance period as set out in advance in the participant’s award agreement.

In determining whether restricted stock or RSUs should be granted, and/or the vesting schedule and other terms applicable to such a stock award, the Plan Administrator may impose whatever conditions as it determines to be appropriate. For example, the Plan Administrator may determine to grant restricted stock or RSUs only if performance goals established by the Plan Administrator are satisfied. Any performance goals may be applied on a company-wide or an individual business unit basis, as determined by the Plan Administrator. Please refer to the discussion below under “— Performance Goals” for information regarding restricted stock and RSUs subject to vesting based on achievement of performance goals.

Unless the Plan Administrator determines otherwise, during the period of restriction, participants holding restricted stock may exercise full voting rights and will be entitled to receive all dividends and other distributions paid, in each case with respect to such shares and, if any such dividends or distributions are paid in shares, the shares will be subject to the same restrictions, including without limitation restrictions on transferability and forfeitability, as the restricted stock with respect to which they were paid.

Participants holding RSUs will hold no voting rights by virtue of such RSUs. The Plan Administrator may, in its sole discretion, award dividend equivalents in connection with the grant of RSUs that may be settled in cash, in shares of equivalent value, or in some combination thereof. Absent a contrary provision in an award agreement, such dividend equivalents shall be subject to the same terms, restrictions and risk of forfeiture as the RSUs with respect to which the dividends accrue and shall not be settled unless and until the related RSUs have vested and been earned.

Stock Bonus Awards

A stock bonus award is an award of shares to an eligible person without a purchase price that is not subject to any restrictions. All stock bonus awards may, but are not required to, be made pursuant to an award agreement. The Plan Administrator will determine the number of shares to be awarded to the participant under a stock bonus award and any other terms applicable to such stock bonus award. Payment of a stock bonus award will be made upon the date(s) determined by the Plan Administrator and set forth in the award agreement. Payment may be made in the form of cash, whole shares, or a combination thereof, based on the fair market value of the shares subject to the stock bonus award on the date of payment, as determined in the sole discretion of the Plan Administrator.

Performance Goals

The Plan Administrator in its discretion may make performance goals applicable to a participant with respect to a stock award, which, depending on the extent to which they are met, may determine whether and the extent to which a stock award will be granted, vested and/or exercisable. In the Plan Administrator’s discretion, one or more of the following performance goals may apply: (i) sales or non-sales revenue; (ii) return on revenues; (iii) operating income; (iv) income or earnings including operating income; (v) income or earnings before or after taxes, interest, depreciation and/or amortization; (vi) income or earnings from continuing operations; (vii) net income; (viii) pre-tax income or after-tax income; (ix) net income excluding amortization of intangible assets, depreciation and impairment of goodwill and intangible assets and/or excluding charges attributable to the adoption of new accounting pronouncements; (x) raising of financing or fundraising; (xi) project financing; (xii) revenue backlog; (xiii) gross margin; (xiv) operating margin or profit margin; (xv) capital expenditures, cost targets, reductions and savings and

TABLE OF CONTENTS

expense management; (xvi) return on assets, return on investment, return on capital, or return on stockholder equity; (xvii) cash flow, free cash flow, cash flow return on investment, net cash provided by operations, or cash flow in excess of cost of capital; (xviii) performance warranty and/or guarantee claims; (xix) stock price or total stockholder return; (xx) earnings or book value per share; (xxi) economic value created; (xxii) pre-tax profit or after-tax profit; (xxiii) strategic business criteria; (xxiv) objective goals relating to divestitures, joint ventures, mergers, acquisitions and similar transactions; (xxv) objective goals relating to staff management, results from staff attitude and/or opinion surveys, staff satisfaction scores, staff safety, staff accident and/or injury rates, compliance, headcount, performance management, completion of critical staff training initiatives; (xxvi) objective goals relating to projects; and (xxvii) enterprise resource planning. Stock awards issued to participants may take into account other criteria (including subjective criteria).

Outside Director Limitations

Stock awards granted during a single fiscal year under the Amended 2022 Plan or otherwise, taken together with any cash fees paid during such fiscal year for services on the Board, shall not exceed $750,000 in total value for any non-employee director (“Outside Director”), except with respect to the first year of service in which case any stock awards granted and cash fees paid will not exceed $1,000,000 in total value (calculating the value of any such stock awards, in each case, based on the grant date fair value of such stock awards for financial reporting purposes). Such applicable limit shall include the value of any stock awards that are received in lieu of all or a portion of any annual committee cash retainers or other similar cash-based payments. Stock awards granted to an individual while he or she was serving in the capacity as an employee or while he or she was an independent contractor but not an Outside Director will not count for purposes of these limitations.

Nontransferability of Stock Awards

Unless determined otherwise by the Plan Administrator, a stock award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the participant, only by the participant. If the Plan Administrator makes a stock award transferable, such stock award will contain such additional terms and conditions as the Plan Administrator deems appropriate; provided, however, that in no event may any stock award be transferred for consideration to a third-party financial institution.

Recoupment Policy

The Plan Administrator may specify in an award agreement that the participant’s rights, payments, and/or benefits with respect to a stock award will be subject to reduction, cancellation, forfeiture, and/or recoupment upon the occurrence of certain specified events, in addition to any applicable vesting, performance or other conditions and restrictions of a stock award. Notwithstanding any provisions to the contrary under the Amended 2022 Plan, stock awards granted under the Amended 2022 Plan are subject to our clawback policy as it may be amended from time to time. The Plan Administrator may require a participant to forfeit or return to and/or reimburse us for all or a portion of the stock award and/or shares issued under the stock award, any amounts paid under, or benefits provided pursuant to, the stock award, and any payments or proceeds paid or provided upon disposition of the shares issued under the stock award, pursuant to the terms of such company policy or as necessary or appropriate to comply with applicable laws.

Adjustment

In the event of a stock split, reverse stock split, stock dividend, combination, consolidation, recapitalization or reclassification of the shares, subdivision of the shares, a rights offering, a reorganization, merger, spin-off, split-up, repurchase, or exchange of our common stock or other securities or other significant corporate transaction, or other change affecting the our common stock occurs, the Plan Administrator, in order to prevent dilution, diminution or enlargement of the benefits or potential benefits intended to be made available under the Amended 2022 Plan, will, in such manner as it may deem equitable, adjust the number, kind and class of securities that may be delivered under the Amended 2022 Plan and/or the number, class, kind and price of securities covered by each outstanding stock award; provided that all such adjustment will be made in a manner that does not result in taxation under Section 409A of the Code.

Corporate Transaction

In the event of a corporate transaction, as defined in the Amended 2022 Plan, each outstanding stock award (vested or unvested) will be treated as the Plan Administrator determines.

TABLE OF CONTENTS

Change in Control

A stock award may be subject to additional acceleration of vesting, settlement, payment and/or expiration upon or after a “change in control” (as defined in the Amended 2022 Plan) as may be provided in the award agreement for such stock award or as may be provided in any other written agreement between us or any of our affiliates and the participant, but in the absence of such provision, no such acceleration will occur.

Amendment, Termination and Duration of the Amended 2022 Plan

The Amended 2022 Plan will continue in effect indefinitely, unless terminated earlier under the terms of the Amended 2022 Plan. The Plan Administrator may at any time amend, alter, suspend or terminate the Amended 2022 Plan.

U.S. Federal Tax Aspects

A participant who receives a stock option or SAR will not have taxable income upon the grant of the stock option or SAR. For nonstatutory stock options and SARs, the participant will recognize ordinary income upon exercise in an amount equal to the excess of the fair market value of the shares over the exercise price — the appreciation value — on the date of exercise. Any additional gain or loss recognized upon any later disposition of the shares generally will be long-term or short-term capital gain or loss, depending on whether the shares are held for more than one year.

The purchase of shares upon exercise of an incentive stock option will not result in any taxable income to the participant, except for purposes of the alternative minimum tax. Gain or loss recognized by the participant on a later sale or other disposition of the shares will be capital gain or loss and/or ordinary income depending upon whether the participant holds the shares transferred upon exercise for a specified period. If the shares are held for the specified period, any gain generally will be taxed at long-term capital-gain rates. If the shares are not held for the specified period, generally any gain up to the excess of the fair market value of the shares on the date of exercise over the exercise price will be treated as ordinary income. Any additional gain generally will be taxable at long-term or short-term capital-gain rates, depending on whether the participant held the shares for more than one year after the exercise date.

A participant who receives restricted stock will not have taxable income until vesting unless the participant timely files an election under Section 83(b) of the Code to be taxed at the time of grant. The participant will recognize ordinary income equal to the fair market value of the shares at the time of vesting less the amount paid for such shares (if any) if no such election is made. Any additional gain or loss recognized upon any later disposition of the shares generally will be long-term or short-term capital gain or loss, depending on whether the shares are held for more than one year. If a participant timely files a Section 83(b) election, the participant will recognize ordinary income equal to the fair market value of the shares at the time of purchase or grant less the amount paid for such shares (if any).

A participant who receives RSUs, performance units or performance shares will not have taxable income upon grant of the stock award; instead, the participant will be taxed upon settlement of the stock award. The participant will recognize ordinary income equal to the fair market value of the shares or the amount of cash received by the participant. In addition, Section 409A of the Code imposes certain restrictions on deferred compensation arrangements. Stock awards that are treated as deferred compensation under Section 409A are intended to meet the requirements of this section of the Code.

The Plan Administrator may, at its discretion and pursuant to such procedures as it may specify from time to time, permit a participant to satisfy such withholding or deduction obligations or any other tax-related items, in whole or in part by (without limitation) paying cash, electing to have us withhold otherwise deliverable cash or shares, or delivering to us already-owned shares; provided that, unless the Plan Administrator permits otherwise, any proceeds derived from a cashless exercise must be an approved broker-assisted cashless exercise or the cash or shares withheld or delivered must be limited to avoid financial accounting charges under applicable accounting guidance or shares must have been previously held for the minimum duration required to avoid financial accounting charges under applicable accounting guidance. The fair market value of the shares to be withheld or delivered will be determined based on such methodology that we deem to be reasonable and in accordance with applicable laws.

We will be entitled to a tax deduction in connection with a stock award under the Amended 2022 Plan only in an amount equal to the ordinary income realized by the participant and at the time the participant recognizes the income. Section 162(m) of the Code places a limit of $1 million on the amount of compensation that we may deduct as a business expense in any year with respect to certain of our most highly paid executive officers. While the Plan Administrator considers the deductibility of compensation as one factor in determining executive compensation, the

TABLE OF CONTENTS

Plan Administrator retains the discretion to award and pay compensation that is not deductible as it believes that it is in the best interests of our stockholders to maintain flexibility in our approach to executive compensation and to structure a program that we consider to be the most effective in attracting, motivating and retaining key employees.

New Plan Benefits

Our named executive officers and non-employee directors have an interest in this proposal as they are eligible to receive equity awards under the Amended 2022 Plan.

The Amended 2022 Plan does not provide for set benefits or amounts of awards and no stock awards have been approved that are conditioned on stockholder approval of the Amended 2022 Plan. However, as discussed in further detail above, our compensation committee and the Board plan to implement the Refresh Program if this Proposal 6 is approved by stockholders. Additionally, in the section entitled “Non-Employee Director Compensation Arrangements,” current non-employee directors who have served on the Board for more than six months will receive on the date of the Annual Meeting an additional stock option or restricted stock unit award, as determined by the Board, with a grant date value of $150,000, which will vest in full upon the earlier of the first anniversary of the date of grant or the day prior to the next annual stockholder meeting, subject to such director’s continuous service through each applicable vesting date.

The following table summarizes the number of shares that our employees, including our executive officers, and non-employee directors will receive initially under the Refresh Program and aggregate value of the shares that our non-employee directors as a group will receive under our non-employee director compensation policy if those that are nominated are elected and remain a director following the Annual Meeting. All other future awards under the Amended 2022 Plan are discretionary and cannot be determined at this time.

As of June 27, 2024, the closing price of our common stock traded on the New York Stock Exchange was $0.1475 per share.

Name and Position	Dollar Value ($)	Number of Shares Subject to Stock Awards (#)^*
Sam Zaid, Former Chief Executive Officer	—	—
Tom Alderman, Chief Financial Officer	—	1,110,000⁽¹⁾
Kasra Sy Fahimi, Former Chief Operating Officer	—	—
All current executive officers as a group (3 persons)	—	2,220,000⁽²⁾
All current non-employee directors as a group (7 persons)⁽³⁾⁽⁴⁾	1,350,000	2,775,000
All employees, including all current officers who are not executive officers, as a group	—	8,880,000⁽⁵⁾

*	See description of Annual Refresh Grants above for information about potential additional equity awards under the Refresh Program.

(1)	Pursuant to the Refresh Program, Mr. Alderman is expected to be granted an Initial Refresh Grant of options to purchase a number of shares representing approximately 10% of the aggregate number of Initial Refresh Shares.

(2)	Pursuant to the Refresh Program, this group of executive officers is expected to be granted Initial Refresh Grants of options to purchase, in the aggregate, a number of shares representing approximately 20% of the aggregate number of Initial Refresh Shares.

(3)

In connection with the implementation of the Refresh Program, each of the non-employee directors is expected to be granted options to purchase, in the aggregate, 550,000 shares of common stock. The number of shares subject to each non-employee director’s stock award under our non-employee director compensation policy will not be determinable until the grant date under the terms of the Amended 2022 Plan. Assuming each of the non-employee director nominees are elected at the Annual Meeting, the amount reflects the standard annual equity award of $150,000 granted to each non-employee director under the terms of the Amended 2022 Plan who have served as directors for at least six months and $300,000 for the initial equity award grant to each of the three non-employee directors appointed in May 2024.

(4)	Mr. Mudrick has unconditionally waived all current and future cash and equity compensation payable to him for his service on our board of directors.

(5)	Pursuant to the Refresh Program, this group of employees is expected to be granted Initial Refresh Grants of options to purchase, in the aggregate, a number of shares representing approximately 80% of the aggregate number of Initial Refresh Shares.

History of Grants under the Equity Incentive Plan

The following table sets forth, with respect to the individuals and groups named below: the aggregate number of shares subject to options granted under the 2022 Plan (whether or not outstanding, vested, or forfeited, as

TABLE OF CONTENTS

applicable) and the aggregate number of shares subject to awards of restricted stock units (including market based restricted stock units assuming maximum performance) granted under the 2022 Plan (whether or not outstanding, vested, or forfeited, as applicable) as of June 27, 2024.

Name of Individual or Group⁽¹⁾	Number of Options Granted (#)	Number of Shares Subject to Stock Awards (#)
Sam Zaid, Former Chief Executive Officer	—	3,747,000
Tom Alderman, Chief Financial Officer	—	546,000
Kasra Sy Fahimi, Former Chief Operating Officer	673,996

Record Date:

Only stockholders of record at the close of business on June 27, 2024, are entitled to notice of, and to vote at, the Annual Meeting and any adjournments thereof.

Proxy Voting:

Each share of common stock that you own represents one vote.

For questions regarding your stock ownership, you may contact us through the Investor Relations section of our website at getaround.com or, if you are a registered holder, contact our transfer agent, Continental Stock Transfer & Trust Company, through its website at www.continentalstock.com or by phone at (800) 509-5586.

SEC Form DEF 14A filed by Getaround Inc.